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ABSTRACT OF THE DISSERTATION 
ORGANOMETALLIC RHENIUM DYES FOR NITRIC OXIDE DETECTION AND 
IMAGING 
by 
Lissette Irene Lozano-Lewis 
Florida International University, 2015 
Miami, Florida 
Professor Konstantinos Kavallieratos, Major Professor 
The importance of sensing Nitric Oxide (NO) in physiology and medicine has led 
us to explore the reactivity of NO with organometallic Re dyes.  Rhenium complexes 
were synthesized with the ability to react with NO and sense it under physiological 
conditions.  Fluorescent 1,10-phenantroline complexes (phen)Re(PPh3)(CO)2OSO2CF3 
(1) and (phen)Re(CH3CN)(CO)2OSO2CF3 (3) can sense NO in the range of 10 - 150 µM 
showing a decrease in fluorescence response at 514 nm  and 532 nm respectively, upon 
NO-donor addition (λexc =  360 nm).  (phen)Re(THF)(CO)2OSO2CF3 (2) showed a 
ratiometric response with a decrease in fluorescence intensity at 585 nm and an increase 
at 445 nm.  These complexes were characterized by FT-IR, 1H-NMR, 13C-NMR, 
and 19F-NMR. The quantum yields (Φ) and lifetimes (τ) were also determined. On the 
basis of 19F-NMR and 1H-NMR spectroscopic evidence, the proposed mechanism of 
action involves dissociation of CF3SO3- (abbreviated as OTf-) together with PPh3, (for 
1),   THF (for 2), or CH3CN (for 3).  Fluorescence microscopy showed that 1 permeates 
through the cell membrane of rat aortic endothelial cells (RAOEC) and 2 gives increase 
in cell fluorescence response at 450 nm when exogenous NO is added to RAOEC. The 
vii 
 
Re complexes of dppz (dppz = 2,2’-dipyrido[3,2-a:2,3’-c]phenazine) 
(dppz)Re(THF)(CO)2OSO2CF3 (A2) and (dppz)Re(CH3CN)(CO)2OSO2CF3) (A3) were 
synthesized using the same methods as for complexes 1 and 3.  Even though the dppz 
complexes  exhibited similar behavior than the phenanthroline analogs, the signal 
changes were small and the results were inconclusive. The α-Diimine Re complexes of 
Xy-DAD (XyDAD = 1,4-bis-[2,6-dimethylphenyl]-1,4-diazo-1,3-butadiene) (Xy-
DAD)Re(THF)(CO)2OSO2CF3 (8) and (Xy-DAD)Re(CH3CN)(CO)2OSO2CF3 (9) 
showed reactivity with NO and CN- with a response in the visible range of the absorption 
spectrum.  These diazadiene (DAD) complexes showed decreased reactivity with NO and 
CN- in the presence of oxidants. The i-PrDAD complexes (i-PrDAD = 1,4-bis-[2,6-
diisopropylphenyl]-1,4-diazo-1,3-butadiene) (i-Pr-DAD)Re(THF)(CO)2OTf (10) and  
(i-Pr-DAD)Re(CH3CN)(CO)2OTf (11) exhibited similar behavior with the Xy-DAD 
analogs, but the spectral changes were much smaller and the results were inconclusive. 
The ESI-MS Mass Spectrometry studies of the phenanthroline complexes 1, and 2, after 
reaction with NO-donor showed that 1 and 2 react with NO to give [Re(CO)2(NO)2S2]+ 
species, while (phen)Re(CO)3Cl and (phen)Re(CO)3OSO2CF3 do not show any metal-
NO containing products, which is consistent with the fluorescence studies. 
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1. INTRODUCTION 
Nitric oxide, or oxidonitrogen (NO),1 is a free radical produced as byproduct of 
nitrogenized fossil fuels and electrical discharges.  Nitric Oxide is catalogued as an 
oxidizer and will both support and propagate combustion.  Because of the presence of 
oxygen, NO is converted into NO2 rapidly in air.  Nitric Oxide is converted to HNO2, 
nitrous acid, in aqueous solutions in the presence of oxygen.   
1.1. BIOLOGICAL ROLES OF NITRIC OXIDE 
The importance of NO in biology and physiology was highlighted in 1998 when 
Drs. Furchgott, Murad and Ignarro won the Nobel Prize in medicine and physiology for 
their research in NO physiology.  Currently, there are over 5,000 publications per year 
that deal with the role of NO in biomedicine.   
In biological systems, NO is involved in signaling and several physiological and 
pathological processes.  Nitric Oxide is short-lived in the blood and is known as an 
endothelial derived relaxing factor (EDRF) because of its vasodilator properties.3 Nitric 
Oxide is produced in cells by the combined role of three isoforms of Nitric Oxide 
Synthase (NOS) enzymes:  i) endothelial (eNOS or NOS-3), ii) neuronal (nNOS or NOS-
1) and iii) inducible (iNOS or NOS-2), the last of which is calcium-dependent.  The 
process involves arginine oxidation followed by the reduction of molecular oxygen.4  
2 
 
 Nitric Oxide is involved in important functions in the smooth muscle, such as 
muscle relaxation, vasodilatation, and regulation of blood flow.5   Nitric Oxide is also 
involved in neuronal activities acts as neurotransmitter.6  It is important in the immune 
system’s attack against pathogens and neoplasia.7   Homeostasis of NO in biological 
systems is a key component of the cellular health.   Nowadays, there is increasing 
research in exogenous NO sources.8   There is a vast selection of novel compounds that 
release NO (or NO-like substrates) to specific targets under special triggers (like nitrites 
under hypoxic conditions).9   Nitric oxide promotes the generation of the messenger 
cyclic 3’,5’-guanosine monophosphate (cGMP), activating the nucleotide-dependent 
protein kinase G (PKG or cGKI).  Protein kinase G is an enzyme involved in the 
phosphorylation of several calcium regulators.10 Actin-myosin dynamic alterations derive 
from varying calcium concentration-sensitization and hyperpolarizing potassium 
channels, which leads to smooth muscle relaxation (Scheme 1.1).10  Nitric Oxide 
functions as an immune system booster, killing invasive bacteria by oxidative damage.11   
However, in extreme cases, these increments in intracellular NO concentration lead to 
profuse vasodilation, causing the hypotension characteristics in sepsis cases or reaching 
cytotoxic levels  leading to an apoptotic cascade.12  
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Scheme 1.1 Stress-induced EDRF-NO mechanism10 
Because of its relatively low polarity, NO is less soluble in oxygen-free water (1.9 
mM) than in organic solvents, such as methanol (14 mM), toluene (11 mM), and hexane 
(18 mM).13 Nitric Oxide is sufficiently lipophilic to permeate through cell membranes.  It 
is oxidized to NO2- in oxygen-containing aqueous solutions with a rate constant ranging 
from 3 x 106 M2 s-1 to 12 x 106 M2 s-1.14    The NO oxidation reaction is 300 times faster 
in aqueous conditions than in hydrophobic conditions.15 Micromolar concentrations of 
NO can trigger formation of reactive nitrogen species, which produces cell damage, 
carcinogenesis, and neurodegenerative disorders.16   
1.2. NITRIC OXIDE QUANTIFICATION 
The quantification of NO17 in tissues remains a challenge because of the absence 
of a detection method that can combine significant spatial and temporal resolution with 
high NO specificity.18   The challenges lie in NO’s short lifetime (t1/2 = ca. 5 s) and the 
fact that it is found in low concentrations in living tissues.  
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Detection methods for NO include chemiluminescence, electrochemistry, and 
spin-trapping followed by EPR (Electron Paramagnetic Resonance).  Chemiluminescence 
is produced when NO is exposed to ozone;19 the limitation of this technique is the 
difficulty of adding the analytes to the detector, making it unsuitable for monitoring NO 
in biological systems.  Another method uses luminol,20  which has the same response as 
peroxides even though it is less cytotoxic than using hydrogen peroxide.  Electrochemical 
microsensors can provide real-time detection;21 but spatial information is limited to the 
electrode tip, making it unsuitable for NO-related biochemistry studies.  EPR has been 
proposed for studies in vitro and in vivo.22   However, as a result of its high reactivity and 
low concentration, NO cannot be reliably quantified by EPR techniques.  In order to 
improve the EPR technique, spin-trapping reagents can be used to form stable radicals, 
giving enough time for detection; There are different types of NO spin trapping reagents: 
nitrone (DMPO) and nitroso (MNP, DBNBS), which are used in cell cultures;23 
nitrosylhemoprotein, ferrous-Hb;24 nitronyl nitroxides;25 Dithiocarbamates/Iron-
dithiocarbamate (DTC/Fe-DTC), which is the only type of spin trapping reagent used in 
vivo;26a Dithiocarbamates have antioxidant properties and react with NO almost at the 
diffusion-controlled rate.27b 
1.3. FLUORESCENT DYES FOR NO SENSING 
Fluorescence imaging is a form of epifluorescence or confocal microscopy in 
which using objective lens focuses the excitation ray going through a pinhole, limiting 
the section of the sample to analyze.27 Fluorescent dyes have been used for quantification 
and imaging of NO at inter- and intracellular concentrations.28 The advantage of such 
dyes is that they can be irradiated at specific intensities and emissive dye-substrate 
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complexes formed upon reaction with NO can be observed.  Some fluorescent dyes have 
high selectivity and can quantify NO at sub-micromolar concentrations.  These dyes can 
be separated into six different groups: i) Dyes based on NO-Induced diamine cyclization 
process; ii) dyes based on NO-Induced diazo-ring-generation process;  iii) based on NO-
Induced spirolactam-ring-opening; iv) dyes based on NO-Triggered selective ligands 
dissociation of Metal complex; v) dyes based on NO-Triggered reduction of copper(II) 
and release of fluorescent ligand; vi) dyes based on NO-Induced spirolactam ring-
opening, reduction of Cu+2, and nitrosylation of fluorescent ligand.    
1.3.1. Dyes based on NO-induced diamine cyclization process:  
NO sensing by these dyes is based on formation of a highly fluorescent triazole in 
the presence of N2O329 (oxidized product of NO in presence of oxygen).  The change in 
response can be attributed to the less electron donating group triazole, disturbing the PET 
process (Photo-Electron Transfer) recovering the fluorescence intensity.  The core of this 
type of fluorescent dye is shown in Scheme 2: 
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Scheme 1.2 Mechanism of NO fluorescent sensors based on NO-induced diamine 
cyclization process17b 
 
These sensors contain different types of fluorophores: i) Fluoresceine,30 e.g., DAF 
and DAF-FM; ii) BODIPY31 (boron dipyrromethene complexes that have stability in 
large ranges of pH); iii) Acridine;32 iv) Anthraquinone;33  v)Tricarbocyanine,34 (highly 
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soluble in water near infrared luminescent probes, designed for human tissue NO 
imaging);  vi) Phosphorescent heavy-metal-complexes as lunimophores,35 (e.g., 
ruthenium-bipy core).  Using this mechanism ratiometric sensors can also be developed, 
in which the ratiometric sensing is realized through the fluorescence resonance energy 
transfer (FRET) process;30d The carbon dots serve as both the energy donor and the 
anchoring site for the NO probe moiety, which turns into the energy acceptor in the 
presence of NO.  
1.3.1.1. Diaminofluorescein (DAF) 
Since 1995, the Nagano group has been developing fluorometric methods to 
detect NO using diaminonaphthalene (DAN).  In the presence of oxygen DAN yields the 
fluorescent naphthalene triazole (NAT) under neutral conditions.36 Fluorescence intensity 
increases incrementally with NO concentration.  However, DAN cannot be used for 
quantification in biological systems because it leaks out through the cell membrane.  
Using the same methodology, Diaminofluorescein (DAF) was shown to react with 
NO/O2, producing DAF-T (triazole) with a small change in absorbance and a large 
increase in fluorescence (180-fold). DAF is suitable for cell studies; its excitation 
wavelength is in the visible range, not making auto-fluorescence possible.37 Different 
series of diaminofluorescein dyes have been synthesized in order to modify the pKa, 
increase quantum yield, increase stability in the presence of pH changes, increase cell 
membrane permeability, decrease autofluorescence, decrease photobleaching, and 
increase cell trappability of the DAF-T complex. 
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Scheme 1.3 DAF-FM mechanism of action toward NO/O2 in the absence 
of extracellular leaking.38 
 
Fluorinated DAFs were shown to be more resistant to photobleaching; DAF-FM 
is the most sensitive and stable within the DAF series,38 with an excitation wavelength of 
488 nm and emission wavelength of 515 nm. It is the most widely used fluorescent probe 
for NO imaging.  Even though the mechanism remains unclear, the fluorescence 
enhancement is ascribed to the interruption of photoinduced electron transfer (PET) 
between the benzoic acid and the xanthene moiety.39 Kinetic studies of NO reactivity 
with DAF-FM, by Tsoukias et al. have shown that the dye response depends on N2O3 
concentration.39d   
Photoinduced electron transfer is a widely accepted mechanism for fluorescence 
quenching.  The fluorescein structure has two parts: the benzoic acid moiety as the PET 
donor and the xanthene ring as the fluorophore. The electron transfer from the PET donor 
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decreases the fluorescence intensity of xanthene.  The small variations between excitation 
and emission wavelengths of DAF and DAF-T can be attributed to the dihedral angle 
between the benzoic acid moiety and the xanthene ring being almost 90°, as shown in the 
X-ray structures of analogous compounds.39c 
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Scheme 1.4 Frontier orbital energy diagram: Illustration of the thermodynamic situation 
of the fluorescence OFF/ON switch including the PET process39  
 
1.3.2. Dyes based on NO-induced diazo-ring-generation  
These fluorophores react with NO, forming a rigid π-conjugation system that 
enhances the fluorescence intensity up to three orders of magnitude,40 as shown in 
Scheme 1.5.  These dyes have low cytotoxicity and cross the cell membranes, but not the 
nuclear membrane.  Anslyn and coworkers have developed a dye which in the presence 
of NO/N2O3 generates a diazo-ring fluorophore.  The dye reacts with NO forming an 
N-nitrosoaniline intermediate, which then undergoes  electrophilic substitution to form 
the diazo- product.  The probe has preference for NO/N2O3 over hydroxyl radical, nitrite, 
nitrate and peroxynitrite.  The product generated is stable in a wide range of pH and the 
fluorescence intensity does not increase over time. 
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Scheme 1.5 Mechanism of NO fluorescent sensors based on NO-induced diazo-ring 
generation process.40 
 
1.3.3. Dyes based on NO-induced spirolactam-ring-opening process:  
These sensors use rhodamine as fluorophore and a reactive lactam group.41 After 
reacting with NO, the lactam ring opens and fluorescence intensity increases because of 
the extension in the conjugation of the rhodamine fluorophore.  The dual fluorophore 
system is used as the Förster resonance energy transfer (FRET) dyad.  There is a change 
in the conjugated system that allows the turn on/off of both dyes.  The system is selective 
toward NO over other competitive radicals and ions.  Although this dye is efficient, its 
synthesis and purification is complex. 
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Scheme 1.6 Mechanism of NO fluorescent sensors based on NO-induced 
spirolactam-ring opening process 
 
1.3.4. Dyes based on NO-triggered ligand dissociation from a metal complex  
Metal to ligand charge transfer (MLCT) between the partially filled d-orbitals of a 
metal and the excited states of the fluorophore can cause fluorescence quenching.  
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Formation of a Metal-NO complex displaces the fluorophore and turns on the 
fluorescence emission (Scheme 1.7).  Using this mechanism of action, Co(II),42 Rh(II),43 
Ru(II),44 Fe(II),45 and Cu(II) complexes have been designed for NO detection.  Most of 
these complexes react directly with NO.  However, they are insoluble or unstable in 
aqueous solutions because water displaces fluorophores from the coordination sphere or 
hydrolyses the fluorophores. 
 
Scheme 1.7 Mechanism of NO fluorescent sensors based on NO-triggered 
dissociation of a fluorescence ligand from a metal complex 
 
1.3.5. Dyes based on NO-triggered reduction of Cu+2 and release of 
fluorescent ligand:   
Most metal nitrosyl complexes described in the previous section will slowly 
hydrolyze if their solutions are exposed to air for several days, as water can outcompete 
the fluorophore for coordination to the metal center.  The metal nitrosyl hydrolysis side 
reaction is why a new type of dye was introduced using Cu(II) complexes for NO 
detection. The new strategy involves the formation of a Cu(I) species via NO-triggered 
reduction of paramagnetic Cu(II) that was associated with NO coordination to a Cu 
center and the release of the fluorescent nitrosylated ligand, corresponding to 
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fluorescence enhancement.  Lippard’s group explored this idea by preparing a new probe 
that include a modified Cyclam ligand in the metal coordination sphere.46  Initially this 
probe was prepared to sense Hg(II).   
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Scheme 1.8 Mechanism of NO fluorescent sensors based on NO-triggered reduction 
of Cu(II) and release of fluorescent ligand 
  
Lippard et al. have developed a series of copper-fluorescein complexes that can 
detect NO under neutral aqueous conditions, in the absence of oxygen.47  The addition of 
hydrolysable esters or conjugation to dextran are used to add cell-trappability.48,49  The 
major improvement compared to DAF is that this dye responds to NO and not to an 
oxidized product of NO.   Cu-FL is selective for NO over hypochlorite, superoxide, 
peroxide, nitrite, nitrate, peroxinitrite and HNO.  The quantum yield of Cu-FL (Φ = 
0.077) is substantially lower than for fluorescein (Φ = 0.95). After reaction with NO and 
elimination of Cu(I), the quantum yield increases again in the nitrosylated fluorescein  
(Φ = 0.58). Thus the mechanism is called turn-off/turn-on. 
1.3.6. Dyes based on NO-induced spirolactam ring-opening, reduction of 
Cu+2, and nitrosylation of fluorescent ligand  
Recently, there have been more examples of sensors that use the combination of 
two or more described mechanisms.   In a recent example, by Duan and coworkers; the 
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dye mode of action combines spirolactam ring opening and reduction of Cu(II).50  The 
mechanism is similar to the one described in the previous section 1.3.5. 
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Scheme 1.9 Dyes based on NO-induced spirolactam ring-opening, reduction of Cu+2, and 
nitrosylation of fluorescent ligand50 
 
1.3.7. Dyes based on NO coordination to a transition metal and detachment 
of a fluorophore 
When a fluorophore is coordinated to a transition metal, its intensity is suppressed 
because of the interaction with the partially filled d-orbitals.  Under the presence of NO, 
NO displaces the fluorophore from the metal center, forming stable nitrosyl complexes 
and the fluorophore regains its initial fluorescence intensity.132   For example, there is  the 
dansylated animotroponimate Co(II) complex prepared by Lippard133 in which a 4-fold 
increase in fluorescence intensity is observed in the presence of NO.  The major 
challenge for these selective dyes is solubility in aqueous physiological media in order 
for them to be suitable for fluorescence cell microscopy.  Many transition metal 
complexes do not pass this challenge.    
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Scheme 1.10 Lippard’s Co(II) complex used as NO sensor. (Figure reproduced 
from reference 133) 
 
1.4. USE OF METALS IN BIOLOGICAL SYSTEMS 
Metals are used in biological systems to perform several roles, such us active sites 
in enzymes, regulators, electrolytes, messengers, transport agents, and transmitters.51 
They also provide accessible scaffolds important for structural stability.52  Table 1.1 
provides a summary of these roles. 
 
 
 
 
 
 
 
 
Table 1.1 Functional roles of inorganic elements applied to biology. 
 
Function Inorganic Element Representative Examples 
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Structure Ru, Rh, Pt 
Kinetically inert complexes serve as structural 
scaffolds that interact in novel ways with 
biomolecules 
Signaling Ca, NO Compounds that release Ca, NO, or other signaling molecules 
Acid-base catalysis Co, Zr, Pt, Ln 
Complexes that induce hydrolytic cleavage of 
biomolecules 
Luminescence Tb, Eu, other Ln Subcellular imaging agents 
Magnetic resonance Gd, Mn Metal-responsive MRI imaging 
Radioactive 
99mTc, 64
Cu, 
others 
SPECT, PET imaging 
X-ray Os, Ln Heavy atom derivatives for biomolecular X-ray structure determination 
Alteration of metal 
bioavailability 
Fe, Cu, 
Zn, Ca, 
other 
Chelating agents that alter normal metal 
homeostasis 
Bonding Zn, Ni, other 
Metal-ligands bond formation for analyte 
sensing, metalloprotein inhibition, or protein 
labeling 
Ligand exchange Gd, Co, others 
Change in coordination sphere to increase MRI 
signal or release bioactive molecule 
Electron transfer Rh, Ru Photoinduced electron transfer to produce potent photooxidants 
Redox Fe, Cu, others 
Oxidative degradation of proteins, DNA; 
chelation to manipulate redox activity 
 
The technicium isotope 99mTc has been used for tumor imaging.53 By using a 
combination of photophysical and radiolabeling, cancer therapy and the treatment 
response can be monitored.54   These two elements have similar electronic properties. 
Technicium and rhenium form analogous complexes with similar physical and chemical 
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properties, these complexes are expected to have the same pharmacokinetic behavior and 
are, therefore, considered a “matched pair” for diagnosis and therapy. 99mTc 
biocomplexes can be used as an alternative to PET radioligands such as 11C,55-56, 18F,57 
and 124I.58  
1.4.1. Metal complexes with fluorescent properties 
Fluorescence microscopy is a resourceful, high-resolution technique that can be 
used for imaging and the study of luminescent molecular probes.  Metal complexes that 
exhibit MLCT usually possess long-lived excited states in the order of hundreds of 
nanoseconds to milliseconds. The long-lived excited state allows the use of time-resolved 
luminescence microscopy (TRLM) in order to eliminate autofluorescence.59 Metal 
complexes can have long Stokes shifts, low cytotoxicity, and high cellular uptake.   
Targeted intracellular localization can be achieved by carefully choosing the 
fluorophores.60 Several transition metals and lanthanides have been used as luminophores 
for in vivo imaging, including Ir(III),61 Pt(II),62 Eu(III),63 and Tb(III).64 
1.4.2. Metal complexes for NO Release 
There are metal complexes that release NO after irradiation.65 The Fe-S-NO 
clusters, such as Roussin’s salt,66 and simple Ru complexes, like [Ru(NO)Cl5]2-, can be 
used for this purpose.67  The PaPy3H (N,N-bis(2-pyridylmethyl)amine-N-ethyl-2-
pyridine-2-carboxamide) group was introduced by Mascharak and coworkers as a 
pentacoordinated ligand that can provide four equatorial nitrogen sites in an octahedral 
metal complex with an apical NO.68  The Ru(II)-PaPy3H complex can release NO and it 
is soluble and stable in aqueous conditions.69  The incorporation of fluorescent dyes into 
NO releasing compounds provides a path for tracking and monitoring targeted cellular 
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NO uptake.70   The promotion of an electron from the metal molecular orbital to a π* 
(NO) antibonding orbital is required for the metal nitrosyl photoactivity.71 The NO-
releasing complexes, which can be excited in the near infrared (NIR) region, are needed 
because of mammalian tissue penetration restriction.72    
Rhenium tricarbonyl complexes have been used for imaging applications because 
of their luminescent properties provided by the 3MLCT: large Stokes shifts, fluorescent 
lifetimes in the hundreds of nanoseconds range, and good quantum yields.73 Lately, it has  
been discovered that these qualities also can be used in biological probes.74  In 
(L)Re(CO)3X type complexes (L = bidentate nitrogen ligand with extended conjugated 
system), the UV-Vis spectrum shows three transitions (Scheme 1.11): (i) a high energy 
band π → π*,  (ii) a lower MLCT energy band  Re → π*(L),  and (iii) a X → L, LLCT 
transition.75 These tricarbonyl complexes exhibit solvatochronism76 and are greatly 
affected by substitutions in the polypyridine ligand.  These complexes possess a Cs 
geometry with three active vibrational modes [A’(1) + A’(2) + A”] corresponding to the 
three CO in facial configuration.77  
N
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Scheme 1.11 UV-Visible transitions observed for (L)Re(CO)3X 
 
1.5. FAMILIES OF NO-DONORS 
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Nitric Oxide has a solubility in water of 2 - 3 mM and reacts rapidly with several 
radicals and water.78 Some advantages of using NO-donors are: Ease of use vs. NO gas, 
targetted delivery, and production modulation in order to avoid side reactions.79 For 
almost 150 years, glyceryl trinitrate (GTN) has been used as an NO-donor for medical 
purposes.80 There are seventeen different classes of NO-donors, which vary from 
enzymatic generators to redox generators.  These NO-donors have different biological 
applications.81  
1.5.1. Organic nitrates (RONO2) 
 Organic nitrates are alcohol nitric acid esters.  Organic nitrates are the oldest 
class, medically applied.  They are synthesized directly from nitric acid and alcohol or 
from alkyl halide and AgNO3.82 They have low solubility in water and they suffer from 
hydrolysis and β-H elimination in alkaline conditions.83 The biggest shortcoming is 
“nitrate tolerance”; even though the mechanism is not clear, it may result in sulfhydryl 
depletion.84  
 
 
1.5.2. Organic nitrites. 
These are esters of alcohols and nitrous acid.  They have been widely used as 
vasodilators.  They can be synthesized by esterification of alcohols with nitrous acid,85  
reaction with other nitrosilating agents, or by transesterification.86  Organic nitrites have 
lower boiling points than the corresponding alcohols, and react rapidly in the presence of 
nucleophiles, transferring the nitrosyl group.87       
1.5.3. Metal-NO complexes 
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This group has been discussed before (1.3.4-1.3.7). Sodium nitroprusside (SNP), 
dinitrosyl iron thiol complexes (DNICs), iron-sulfur clusters nitrosyl, ruthenium nitrosyls, 
and iron-porphyrin nitrosyls are members of the Metal-NO family.  
1.5.4. N-Nitrosamines 
N-nitrosamines have been used sparingly as solvents or intermediates in the 
synthesis of hydrazines and diazoalkanes.88 They are considered carcinogenic because 
they can alkylate biomolecules.89 
1.5.5. N-hydroxy-N-Nitrosamines. 
N-hydroxy-N-Nitrosamines decompose to generate NO under physiological 
conditions. Therefore, they can be used as anti-hypertensive agents and inhibitors of 
platelet aggregation.90 They are prepared by direct nitrosation of N-hydroxyamines.91  
Cupferron is used in extraction, separation, and colorimetric detection of metals.92  It 
releases NO under enzymatic,93 electrochemical,94 and oxidative conditions.95 
1.5.6. N-Nitrosimines. 
Heterocyclic compounds produced from the correspondent imines.  There are 
seven subtypes according to the substituents.96 They release either NO or N2O from the 
decomposition of HNO.  In the presence of thiols, the production of N2O is favored over 
NO. 
1.5.7. Nitrosothiols (RSNOs). 
Nitrosothiols were first synthesized in 1909.97 There are few RSNOs that are 
stable.   They are proposed as storing, transfering and delivering vehicles for NO.  They 
are synthesized from thiols and NO derivatives.98 The reaction rates with NO are 
influenced by steric effects; bulky substrates react slower than less hindered ones.99    
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1.5.8. C-Nitroso compounds 
Tertiary C-nitroso compounds with germinal electron withdrawing groups can be 
used as NO-donors.  These compounds are prepared from their corresponding 
hydroxylamines.100 They release NO under thermolysis and photolysis.101 In biological 
systems, they can produce in vitro vasodilation and decrease the presence of 
oxyhemoglobin.102   
1.5.9. Diazetine dioxides 
These four-member ring heterocycles were first introduced in 1971.103 They 
decompose in physiological aqueous solutions.104 Diazetine dioxides were used to 
decrease the systolic high blood pressure in rats.105  
1.5.10. Furoxans and benzofuroxans. 
These five member heterocycles may lead to positive and negative biological 
outcomes.106 These compounds are thermally stable; they are reactive in presence of 
nucleophiles and bases.  They release NO in presence of thiols107 and undergo ring 
opening reactions with biological thiols, such as cysteine or glutathione.108    
 
1.5.11. Oxatriazole-5-imines 
These mesoionic substituted five-member heterocycles were first reported in 
1965.109 They have been used as blood pressure depressants.110  They were initially 
synthesized from monohydrazines through substituted cyanohydrazines.111  
1.5.12. Sidnonimines 
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Sidnonimines is an important class of NO-donors112 introduced in 1957.113 These 
reagents produce stoichiometric amounts of superoxide anions; NO and superoxide react 
with each other, producing peroxynitrite.  Their metabolites are potent vasorelaxants.114 
1.5.13. Oximes 
The alkyl- and aryl- oximes can be converted to NO under oxidative 
conditions.115  These compounds are vasoactive, with similar activity to NO.  They are 
synthesized by addition of a nitro and a hydroxyimino group into a diene by a nitro-
nitrosation step.116 Oximes decompose into NO and the corresponding ketone, under 
physiological conditions.117  
1.5.14. Hydroxylamines:  
Hydroxylamines are hygroscopic free-base products of mammalian cells.118 In 
alkaline solutions, they disproportionate into ammonia, nitrogen and nitrous oxide.  
Hydroxylamines can produce NO under enzymatic conditions.119  
1.5.15. N-Hydroxyguanidines 
N-Hydroxyguanidines are products of guanidine and hydroxyurea that exhibit 
cytotoxicity against leukemic cells and antitumor activity in vivo.120 In contrast to other 
NO-donors, hydroxyguanidines do not produce NO spontaneously: They need NOS121 or 
P450122 enzymes to produce NO. 
1.5.16. Hydroxyurea 
Hydroxyurea is a well-known antitumor agent.123 It shows some activity against 
some cancers,124 skin diseases,125 and inhibits HIV virus replication.126 In 1998, the first 
in vitro reaction of oxyhemoglobin with hydroxyurea was reported.  It involved the 
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specific transfer of NO from the NHOH group of hydroxyurea in biomolecules taken 
from sickle cell anemia patients.127 
1.5.17. Zwitterionic polyamine/NO adducts (NONOates) 
Bubbling NO to amines produces RN[N(O)NO]-(CH2)xNH2+.128 The half-lives at 
physiological conditions may vary from 1.8 min to 56 h, depending on the amine 
substituents.129  These adducts are affected by slow decomposition even in the solid state, 
and thus are stored at low temperatures (-78 °C).130  NONOates may release two full 
equivalents of NO in solution131  and some have extended shelf life. 
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Scheme 1.12 Structure of a generic zwitterionic NONOate. 
 
 
 
 
 
 
 
 
Table 1.2 Spectroscopic properties and NO-release half-lives for different NONOate type 
NO-donors.  Measured in 0.01 M NaOH.  Determined at 22 °C and pH 7.4 in 0.1 M 
phosphate buffer. 
 
RN[N(O)NO]-(CH2)xNH2+R' 
x R R' 
UV λmax  
(nm) 
ε x 10-3  
(M-1cm-1) t1/2 (min) 
2 Me Me 250 7.31 36.1 
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3 Me Me 250 7.68 10.1 
4 Me Me 250 8.59 1.3 
6 Me Me 250 7.25 3.7 
2 Me H 250 7.8 40 
2 Et H 250 7.96 333 
2 Et Et 250 7.61 327 
3 Me H 250 7.77 13.7 
3 Et Et 250 8.55 71.8 
3 Pr H 250 8.05 76.6 
3 i-Pr H 250 7.44 93 
3 i-Pr i-Pr 250 7.89 88.5 
3 cyclohex H 250 9.13 115 
2 (CH2)2NH2 H 252 7.64 3400 
3 (CH2)3NH2 H 252 7.83 284 
3 (CH2)4NH2 H 250 9.42 165 
 
1.6. PROJECT RATIONALE 
The objective of this project is the synthesis, characterization and NO sensing and 
imaging study of Re-based ratiometric fluorescent dyes.   The unique mechanism we 
envisioned for NO sensing depends on change in fluorescence properties that occurs upon 
NO coordination. In order to obtain a ratiometric fluorescent probe that can detect 
changes in NO concentration with high sensitivity and selectivity, an entirely new 
approach on NO sensing is employed that combines the following elements: 1) NO 
binding to a metal center, such as Re(I); 2) a bidentate or tridentate phenathroline (phen), 
dipyridophenazine (dppz), or α-diimine framework attached on the metal, which provides 
favorable photophysical characteristics, as well potential for modification; and 3) two 
weakly-coordinated ligands: i) The X-type CF3SO3- and ii) An L-type ligand, such as 
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THF, CH3CN, or PPh3.  The sensing mechanism may involve the formation of nitrosyl 
complexes with concurrent alteration of photophysical properties of an organometallic 
complex upon reaction with NO. 
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Scheme 1.13 Proposed mechanism for the ratiometric response for Re-based NO sensors. 
 
The mechanism of NO sensing is based on the optical and photophysical 
properties of rhenium, and the affinity that rhenium has for Nitric Oxide (NO) to form 
nitrosyl complexes.  These complexes sense NO in aqueous media, at 37 °C and pH 7 
and are expected to be able to permeate the cell membrane and get trapped in the 
cytosolic media.  The strong 3MLCT is a result of the presence of carbonyl groups. 
Dissociation of labile ligands (L and CF3SO3-) and NO attachment leads to a different 
fluorescence maximum, promoting ratiometric response.  Aromatic ligands 
(polypyridines, phenanthrolines) can give this probe membrane cell permeability, 
providing the complex is neutral. Change in polarity or overall charge of the complex 
upon NO reaction could potentially trap the product inside the cell. 
Previous attempts of rhenium phenanthroline complexes35b as NO sensors have 
used diaminopyridine, which transforms into a triazole in a mechanism similar to DAF 
family of dyes (1.3.1). In those dyes there was no coordination of NO to Re.     
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Rhenium Tricarbonyl [Re(CO)3(N-N)(X)]+ systems: This type of kinetically inert Re(I) 
d6 18-electron complexes displays a 3MLCT phosphorescent emission after near visible 
ultra-violet and visible light excitation.  The function of these carbonyl ligands is to avoid 
the deactivation of Re(I) metal center. The 3MLCT transition is characteristic of d6-
Rhenium(I)-carbonyl complexes.  There are also non-carbonyl rhenium complexes that 
able to display this transition. However, their ligand field splitting is very small; for 
example, Re(bipy)3 is non-luminescent. Several other ligands like polypyridines, bis-
quinolines and pyridazines have been studied as probes for cell imaging.134      
  Rhenium imaging probes have shown reliable responses.   Changing fluorophores 
selectively may target different subcellular structures.  Rhenium(I) reacts with specific 
biochemical agents localized in the cell, such as sulfur-containing aminoacids in the 
mitochondria, or with macromolecules by non-covalent interactions.  None of these 
precursors uses NO-triggered selective ligand dissociation from a metal complex, as a 
mechanism to provide NO sensing with a ratiometric response.  The proposed probe is 
expected to selectively sense NO even under anaerobic conditions, because it does not 
need O2 for activation. Several current NO dyes respond to NO indirectly with the real 
substrates being N2O3 or NO2 radical formed by reaction of NO with oxygen. The Re-
NO dyes we propose are soluble in aqueous media, (pH between 7.2 and 7.4), by using 
only a minimum amount of organic solvent. In order for the Re-NO dyes to meet 
requirements for widespread applicability, they need to be stable under physiological 
conditions, permeable through the cell membranes and modifiable to be trapped inside 
the cell.  
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2. (phen)Re(PPh3)(CO)2OSO2CF3 AS AN ORGANOMETALLIC 
FLUORESCENT NO SENSOR. 
2.1. ABSTRACT 
The compound (phen)Re(PPh3)(CO)2OSO2CF3 (1), which can be obtained 
photochemically or thermally from (phen)Re(CO)3OSO2CF3 shows ratiometric 
fluorescence sensing response upon NO addition, which was  added in the form of  NO-
donor Z-1-N-methyl-N-[6-(N-methylammoniohexyl)amino]diazen-1-ium-1,2-diolate 
(MAHMA-NONOate). Addition of 10-150 µM of NO-donor into a 25 µM solution of 
(phen)Re(PPh3)(CO)2OSO2CF3 in 25% v/v acetone/phosphate saline (PBS) buffer gave 
fluorescence quenching at 518 nm, and fluorescene enhancement at 426 nm upon 
excitation at 360 nm. The FT-IR spectra after reaction with NO showed bands at 1720 
cm-1 and 1631cm-1 that can be ascribed to Re-NO complex formation. The 1H-NMR 
and 19F-NMR spectra after reaction with NO showed characteristic resonances for non-
coordinated triflate and PPh3, suggesting that the organometallic product formed upon 
reaction with NO releases both these ligands.   Fluorescence microscopy studies on Rat 
Aortic Endothelial Cells in 2% v/v acetone/phosphate saline (PBS) buffer showed distinct 
incorporation of the dye into cells. Compound 1 is an isolable complex, which is stable at 
room temperature and therefore can be used as an NO sensing organometallic dye, as 
prepared, without further treatment. 
2.2. INTRODUCTION 
Nitric Oxide sensing has been a topic of intense research interest since the early 
90’s (references 1-16 in Chapter 1). Diaminofluoresceins (DAF) are the most commonly 
used dyes for fluorescent detection, because of their high sensitivity and good cell 
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absorptivity.1 However DAF-like sensors have a complex NO sensing mechanism, that 
relies on activation of NO with dioxygen.2  Another strategy for selective sensing of NO 
is by using metal-containing dyes, such as fluorescein containing-Cu(II) and Fe(III) 
centers introduced by Lippard et al.3  Surprisingly, third-row transition metal 
organometallics, have found very limited application to NO sensing, despite their well-
studied photophysical properties and ability to bind NO. Several transition metal nitrosyl 
complexes have been reported,4 including some Re(I) complexes.5 There are only a few 
reported examples of mixed-ligand phosphine/nitrosyl rhenium complexes.6  These 
complexes are typically synthesized from rhenium nitrosyls, but not vice-versa.7    
Several Re(I) complexes have photoluminescent properties8 and exhibit 
photoactivity in solution because of metal-to-ligand charge transfer (MLCT).9  Control of 
Re(I) photochemical, photophysical, and electrochemical properties has generated 
interest because of the use of these complexes as electro- and photocatalysts.10  Typically, 
Re-phosphine complexes have higher quantum yields than [Ru(bipy)3]2+.11 Excited state 
properties of diimine rhenium(I) carbonyl complexes occur in the lowest triplet excited 
state, because of non-radiative processes that occur from the highest vibrational energy 
levels.12   The nature of the π-acceptor ligand (diimine or bridging ligand) determines the 
photophysical/photochemical properties.  Mononuclear diimine rhenium(I) carbonyl 
complexes have quantum yields varying from 0.001 to 0.1 and long emission lifetimes 
(10 ns to 1 µs) as result of the lowest energy MLCT.13  There are two general methods for 
tuning the metal complex photophysical properties: (a) using a ligand with a different 
field strength to adjust the energy of the bonding orbitals in the metal center; (b) adding 
different substituents to the diimine ligand to alter the π* orbital energy level, producing 
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a change in the absorption/emission wavelength, within the desired window range.13 
Recently, a Re(I)-phenanthroline-tricarbonyl-pyridine complex showed fluorescence 
enhancement upon NO addition. The fluorescence change is a result of triazole 
formation, occurring after oxidative reaction with activated NO (in the form of N2O3) in 
a similar fashion as DAF-FM.14  This compound was not found to be responsive in cells 
upon exogenous NO-donor addition.  Our research group has recently proposed a new 
method for NO sensing and detection based on the favorable photophysical and NO 
complexation properties of metal polypyridine complexes and analogs.15 
The triphenylphosphine organometallic complex (phen)Re(PPh3)(CO)2OSO2CF3 
(1) introduced in this Chapter showed fluorescence responses, that can be ascribed 
directly to NO complexation by Re, as indicated by NMR and IR spectroscopic studies. 1 
also has the additional advantages that it can be prepared in an isolable form, and is stable 
at room temperature. Preliminary fluorescence microcopy studies in cells have shown 
good absorptivity, thus indicating its promise a fluorescent probe for nitric oxide 
imaging. 
2.3. EXPERIMENTAL SECTION 
2.3.1. Materials and Methods 
(phen)Re(CO)3Cl and (phen)Re(CO)3OSO2CF3 were prepared as previously 
reported and were found spectroscopically identical  to the reported compounds.16,17 All 
other materials (purchased from Aldrich Chemical Co., ACROS Organics, Cayman 
Chemicals, or Alfa Aesar) were standard reagent grade and were used without further 
purification, unless otherwise noted.  Tetrahydrofuran (THF) used for the preparation of 
1, was anhydrous (purchased as an Aldrich Sure-Seal™ product), or distilled and dried 
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before use. PBS buffers A (0.002 M in total phosphate , pH = 7.2, [NaCl] = 0.04 M) and 
B (0.002 M in total phosphate, pH = 7.2, [NaCl] = 0.02 M) were prepared from K2HPO4, 
KH2PO4, and NaCl (all from Fisher Scientific). Water used for preparation of the buffers 
and experiments with Nitric oxide was filtered water (18 MΩ·cm-1) produced from a 
Millipore® nanopure diamond lab water system (Barnstead Thermolyne Corporation, 
Dubuque, IA). Deuterated solvents were purchased from Cambridge Isotope Laboratories 
Ltd. Rat Aortic Endothelial Cells were acquired from Cell Biologics. Fetal Bovine Serum 
(FBS) and DMSO were bought from ATCC Inc. Penicillin-Streptomycin and endothelial 
cell growth supplement from bovine neural tissue were purchased from Sigma-Aldrich. 
DMEM/F-12 medium, PBS (for fluoresence microscopy experiments) and Trypsin 
(0.05% EDTA) were purchased from GIBCO/Invitrogen Inc. Cell culture flasks and 
dishes were purchased from Fisher Scientific. Photochemical reactions were carried out 
using a Rayonet photochemical reactor (Southern New England Ultraviolet, model RPR-
100), equipped with a cooling fan and 10 phosphor-coated low-pressure mercury lamps 
(λmax = 300 nm, light intensity = 5.2 ± 0.1 × 106 photon/sec/cm3). Fluorescence Spectra 
were recorded on a Jobin Yvon Horiba Fluoromax-3 fluorimeter. Fluorescence 
Microscopy was performed using an Olympus IX-81 Fluorescence Microscope and 
analyzed with IPLab v 4.04 Scientific Imaging Processing Software.  Frequency-domain 
fluorescence lifetime measurements were performed using a ChronosFD 
spectrofluorometer (ISS, Champaign, IL). Samples were excited with a 370 nm 
modulated diode, and emission was collected using 400 nm long-pass filters (Andover, 
Salem, NH).  The 1H and the 13C-NMR spectra were recorded on a 400 MHz Bruker 
NMR spectrometer and were referenced, using the residual solvent resonances. All 
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chemical shifts, δ, are reported in ppm. The FT-IR spectra were recorded on a Perkin-
Elmer Spectrum 100 FT-IR Spectrometer. 
2.3.2. Synthesis of (phen)Re(PPh3)(CO)2OSO2CF3:  
Method 1 - Thermal Substitution: 20.0 mg of (phen)Re(CO)3OSO2CF3 (33.3 µmol) and 
10 mL of THF (final concentration: 3.33 mM) were placed in a 50 mL round bottom 
flask, under N2 flow. The solution was refluxed for 48 h.  The color changed during 
reflux from yellow to amber.  The volatiles were evaporated to dryness and 1.0 mL of 
dichloromethane was added. The product was precipitated at room temperature by adding 
4.0 mL of diethyl ether.  The bright yellow powder product was filtered and was dried in 
vacuo at 40 oC.  20.5 mg, (74%). 1H-NMR (CDCl3): 6.96 (t, 3H, 3JH-H = 7.0 Hz), 7.39 
(dd, 6H, 3JH-H = 7.6 Hz, 3JH-H = 2.0 Hz), 7.62 (dd, 6H, 3JH-H = 12.5 Hz, 3JH-H = 7.2 Hz), 
7.95 (d, 2H, 3JH-H = 8.2 Hz, 3JH-H = 5.1 Hz), 8.36 (s, 2H), 8.99 (d, 2H, 3JH-H = 8.28 Hz), 
9.14 (d, 2H, 3JH-H = 4.7 Hz). 13C-{1H}-NMR (CDCl3): 128.92 (p-CH, s, 3C), 129.15 (m-
CH, d, 6C, 3JC-P = 37.8 Hz), 131.23 (CH, s, 2C), 132.38 (o-CH, d, 6C, 1JC-P = 40.5 Hz), 
137.14 (CH, s, 2C), 140.04 (CH, s, 2C), 153.32 (CH, s, 2C).  19F-{1H}-NMR (CDCl3): -
78.3 ppm FT-IR (cm-1): 2029 (νCO, s), 1926 (νCO, s), 1906 (νCO, s), 1433, 1266, 1152, 
1031, 854, 725, 638.  Anal. Calc. C33H23F3N2O6PReS: C 46.64%, H 2.72%, N 3.29%. 
Found:          C 46.28%, H 2.32%, N 3.20%. UV-Vis (in ethanol): λmax = 360 nm (ε = 
4500 mol-1cm-1), fluorescence emission in acetone (λexc = 360nm): 585nm Φ1=0.027 (at 
370 nm, in 1:3 acetone/PBS buffer, using quinine sulfate in sulfuric acid 0.1 M as 
reference ΦR=0.546).   
Lifetime method 1: Frequency dependent, useful for fast lifetimes: τ1 = 21.3 ± 0.3 ns,     
f1 = 0.0626 ± 0.0008, α1 = 0.00294; τ2 = 389 ± 5 ns, f2 = 0.601 ± 0.007, α2 = 0.00155.  
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Lifetime method 2: Time-dependent, useful for slow lifetimes: τ1  = 35.4 ± 0.05 ns, f1 = 
0.869 ± 0.047; τ2 = 225 ± 0.06 ns, f2 = 0.094 ± 0.0003; τ3 = 1995 ± 15 ns, f3 = 0.006 ± 
0.00003; with fluorescence still observable after 1 µs.  Differences between the two 
methods can be attributable to in the second method the values are result of an 
algorithmic fitting instead of real measurement. 
Method 2 - Photochemical Substitution: 1.0 mg of (phen)Re(CO)3OSO2CF3 (1.67 µmol), 
3.0 mg of triphenylphosphine and 1.00 mL of THF (final concentration 1.67 mM) were 
placed in a NMR tube. The solution was irradiated with a photochemical reactor (λmax = 
300 nm, light intensity = 5.2 ± 0.1 × 106 photon/sec/cm3).  After irradiation the color of 
the solution changed from yellow to amber.  This solution was used without further 
treatment.  FT-IR (cm-1): 2029 (νCO, vs), 1921 (νCO, vs), 1905 (νCO, vs), 1722 (νCO-O, 
vs), 1633 (νCO-O, vs), 1437, 1279, 1261, 1180, 1118, 1030, 749, 693, 637.   
2.3.3. Fluorescence experiments with NO-donor  
In a typical experiment, 1.000 mL of a solution of 
(phen)Re(THF)(CO)2OSO2CF3 or (phen)Re(PPh3)(CO)2OSO2CF3 complex (100 µM) 
was prepared by dilution with acetone of a 1.67 mM THF stock solution.  Aqueous PBS 
buffer A (pH=7.2, [NaCl] = 0.04 M, 2.75 mL to 3.00 mL) was added. Then 0-250 µL of 
4 mM stock solution of MAHMA-NONOate NO-donor, in 0.04 M NaOH were added, in 
order to obtain 75% v/v aqueous/organic solution and a final NO-donor concentration in 
the  0-200 µM range, while the concentration of the Re complex remains constant at 25 
µM. No more than 10 min. elapsed from preparation of the organic phase to the addition 
of NO-donor. The solution was mixed thoroughly in a vortex and sonicated for 90 min. at 
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room temperature.  The fluorescence of all solutions was measured at λexc = 360 nm and 
recorded from 400 nm to 700 nm.  For a control experiment a NaOH stock solution was 
used instead of an NO-donor/NaOH stock, in order to account for any possible variations 
in the fluorescence due to minor pH changes. The result of the control titrations gave 
identical spectra for all titration points in the 1-150 µL range. These experiments were 
also performed in identical conditions for control compounds (phen)Re(CO)3Cl and 
(phen)Re(CO)3OTf and no significant changes were observed for their fluorescence 
emissions upon NO addition.  
2.3.4. Fluorescence titrations with gradual addition of NO-donor under 
anaerobic and aerobic conditions.  
In a typical experiment, 0.750 mL of a (phen)Re(THF)(CO)2OSO2CF3 or 
(phen)Re(PPh3)(CO)2OSO2CF3 solution (100 µM) was prepared from dilution of 20 µL 
of a 1.67 mM THF stock solution with acetone.   A quantity of 2.25 mL of aqueous PBS 
buffer A (pH=7.2, [NaCl] = 0.04 M) was added. The fluorescence emission was 
monitored using λexc = 360 nm. Then 3 mM stock solution of MAHMA-NONOate     
NO-donor in 0.04 M NaOH was added progressively 300 µL in 25 µL portions.  After 
each addition, the solution was left react for 10 minutes (approximately 3 MAHMA 
NONOate half-life), at room temperature before measuring fluorescence using the same 
parameters as above.   
2.3.5. Fluorescence titrations with low concentrations of NO-donor.  
In a typical experiment, 0.750 mL of a (phen)Re(THF)(CO)2OSO2CF3 or 
(phen)Re(PPh3)(CO)2OSO2CF3 solution (100 µM) was prepared from dilution of 20 µL 
of a 1.67 mM THF stock solution with acetone.   A quantity of 2.25 mL of aqueous PBS 
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buffer B (pH=7.2, [NaCl] = 0.02 M) was added.  The solution was bubbled with nitrogen 
for 30 minutes.  The fluorescence emission was monitored using λexc = 360 nm. Then 3 
mM stock solution of MAHMA-NONOate     NO-donor in 0.04 M NaOH was added 
progressively 150 µL in 1 - 25 µL portions.  After each addition, the solution was left 
react for 10 minutes (approximately 3 MAHMA NONOate half-life), at room 
temperature before measuring fluorescence using the same parameters as above.   
2.3.6. 1H-NMR and 19F-NMR study of reactivity of Re complexes with NO: 
(phen)Re(PPh3)(CO)2OSO2CF3 (1 mg) was added to 0.05 mL of THF in four 
separate 10 mL vials. Acetone (1.6 mL) was added to each vial.   Then 2.4 mL of PBS 
buffer A (pH=7.2, [NaCl] = 0.04 M) and 0.2 mL of stock NO-donor solution (5 mM in 
0.04 M NaOH) were added sequentially.  The solutions were vortexed for 30 sec. and 
then sonicated for 3h at room temperature. Dichloromethane was added (3 x 10 mL), and 
the organic layer was dried with anhydrous sodium sulfate.  The solvent was evaporated 
and the non-volatiles were taken up in chloroform-D and the NMR spectra were 
collected.   In order to remove uncomplexed phenanthroline products and collect only the 
NMR spectra of complexes, the organic phases were further diluted with 
dichloromethane and washed with 1 M hydrochloric acid, followed by 1 M sodium 
bicarbonate, rinsed with deionized water, and dried with anhydrous sodium sulfate.  The 
volatiles were evaporated, the solid residues were redissolved in chloroform-D, and 
the 1H-NMR and 19F-NMR spectra were recorded. These experiments were also 
performed under identical conditions for control compounds (phen)Re(CO)3Cl and 
(phen)Re(CO)3OTf. After HCl/NaHCO3 washing no changes were observed in the 1H-
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NMR spectrum of (phen)Re(CO)3Cl, while for (phen)Re(CO)3OTf, resonances identical 
to (phen)Re(CO)3Cl were observed.  
2.3.7. Fluorescence microscopy studies of (phen)Re(PPh3)(CO)2OSO2CF3 
in Rat Aortic Endothelial Cells: 
Cell preparation: Rat Aortic Endothelial Cells were grown in Dublecco’s Modified Eagle 
Medium: Nutrient Mixture F-12 medium (DMEM/F-12) supplemented with 10% Fetal 
Bovine Serum (FBS), 1% penicillin-streptomycin, and endothelial cell growth 
supplement in a humidified tissue culture incubator at 37oC equilibrated with 95/5 v/v% 
Air/CO2 mixture. Cells were cultured in 35 × 10 mm dishes seeded with 2 × 105 cells and 
used at 60-80% confluency. 
Solution Preparation: A 500 µM solution of Re(phen)(THF)(CO)2OSO3CF3 in 
THF/acetone (Solution B) was prepared from dilution of 62.5 µL of a stock solution of 
Re(phen)(THF)(CO)2OSO3CF3 in THF (1.6 x 10-3 M - Solution A) with 138 µL of 
acetone.  This solution was added to 800 µL of commercial 10 mM PBS buffer solution 
(pH=7.2), resulting in a final 100 µM solution of 1 in 80/14/6 v/v aqueous 
buffer/acetone/THF. This new solution was further diluted 1/10 v/v with PBS Buffer 
before adding it to the cells, resulting in a final solution of 10 µM of 1 in 98/1.4/0.6 v/v 
aqueous PBS buffer/acetone/THF (Solution C). Various quantities of 6 mM NO-donor 
solution (MAHMA-NONOate) in 0.01 M NaOH were diluted with 0.01 M NaOH to give 
0, 100, 500 & 1000 µM solutions of NO-donor (Solutions D-G).   
Loading of solution C (10 µM of Re complex 1):  The old media were poured out from the 
plates; then the plates were rinsed twice with 1 mL of 10 mM PBS (pH = 7.2). Then 100 
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µL of DMEM/FBS/Penicillin Media, 800 µL of PBS 10 mM, and 100 µL of Re complex 
stock (Solution C) were added with this specific order. The plates were incubated for 75 
min. at 37 oC equilibrated with 95/5 v/v% Air/CO2 mixture. 
Fluorescence Microscopy Measurements:  Each plate was placed in the fluorescence 
microscope and measured under a filter an excitation wavelength of 350 nm (330-380 nm 
window) and an emission window of 440-460 nm.  The images were collected with a 
total exposure time of 2668 ms and 20X zoom. 
2.4. RESULTS AND DISCUSSION 
2.4.1. Synthesis of (phen)Re(PPh3)(CO)2OSO2CF3 (1) 
Complex 1 was synthesized by photochemical or thermal substitution of CO from 
(phen)Re(CO)3SO3CF3. Only the thermal preparation was performed on a larger scale 
and led to an isolable quantity of the product. However the product was found to have 
identical UV-Vis and NMR spectra, regardless of the preparation method. The isolated 
product was characterized by 1H-NMR,13C-NMR, and FT-IR, and its purity was 
confirmed by elemental analysis. 
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Scheme 2.1 Synthesis of (phen)Re(PPh3)(CO)2OSO2CF3 (1) 
2.4.2. Fluorescence studies with addition of NO-donor  
Complex 1 showed significant fluorescence response to NO addition. The 
fluorescence spectrum of 1 in acetone/buffer 25/75 v/v shows one emission at 514 nm 
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(Φ = 0.03). Figure 2.1 shows the effects on the fluorescence spectrum of 1 upon NO 
gradual addition, in the form of NO-donor MAHMA-NONOate (0 - 150µM) dissolved 
in 0.04 M NaOH. The emission at 514 nm decreases rapidly upon NO addition and its 
intensity shows linear dependence with NO-donor concentration, thus allowing NO 
quantification in the 0-150 µM range (Figure 2.2).  
 
Figure 2.1 Fluorescence Response upon NO-donor addition (0-150 µM) to 20 µM of Re 
complex 1 in acetone/PBS aqueous buffer 25/75 v/v, (λexc = 360 nm) 
 
A control experiment in the absence of NO-donor, (addition of 0.04 M NaOH) 
shows no observable changes in fluorescence intensity, proving that the sensor responds 
to NO-donor addition and not any other substance present in the matrix of the added 
solution (Figure 2.2).  It should also be noted that by using a 0.002 M PBS buffer, in 
0.04 M NaCl, and a NaOH 0.04 M solution for the N donor no precipitation is 
obdserved under the concentration range of these experiments. These experiments were 
also performed in identical conditions for control compounds (phen)Re(CO)3Cl and 
(phen)Re(CO)3OTf and no significant changes were observed at their fluorescence 
[NO donor] 
0 – 150 µM 
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emissions at 565 nm, upon NO addition, indicating that the presence of a labile L ligand 
is necessary for reaction with NO.  
 
Figure 2.2 Observed Fluorescence intensities of 1 (20 µM) at λmax = 514 nm upon        
NO-donor addition vs addition of control solution (NaOH 0.04 M). λexc=360 nm. 
 
Complex 1 prepared photochemically on a 1 mg scale (1.67 mM in THF) showed 
also significant fluorescence response to NO addition both at 560 nm (decrease) and at 
455 nm (increase). The fluorescence spectrum of 1 in THF/acetone/buffer 2/23/75  
shows one emission at 562 nm. The shift in emission compared to the isolated complex 
could be ascrtibed both to the difference in the solvent system, and the presence of 
unreacted (phen)Re(CO)3SO3CF3, or (phen)Re(CO)2(THF)SO3CF3 which emit at 562 
nm and 535 nm respectively (see Chapter 3). Figure 2.3 shows the effects on the 
fluorescence spectrum of 1 upon NO gradual addition, in the form of NO-donor 
MAHMA-NONOate (0-150µM) dissolved in 0.04 M NaOH. The emission at 560 nm 
decreases rapidly upon NO addition (with a gradual low-energy shift), while the increase 
[NO donor] (mM) 
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at 452 nm is more pronounced a higher NO-donor concentrations leading to a pseudo-
ratiometric response, and an “isosbestic area” at 485 nm.  
 
Figure 2.3 Fluorescence Response upon NO-donor addition (0 - 150 µM) to 25 µM of 
Re complex 1 prepared photochemically, used as THF solution, in acetone/PBS aqueous 
buffer 25/75 v/v  (λexc = 360 nm) 
 
The plot of intensity ratio for the two signals at 452 nm and 562 nm vs.           
NO-donor concentration, (Figure 2.4) allows NO quantification using the ratio of the 
two responses.  The rapid increase on the ratiometric response for higher NO 
concentrations are result of to the different range of NO in which the intensities at 565 
nm and 454 nm are most sensitive. Specifically the 562 nm intensity decrease shows 
high sensitivity for low NO concentration, while the increase at 452 nm becomes more 
notable for high concentrations.    
[NO donor] 
0 – 150 µM 
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Figure 2.4 Fluorescence intensity ratio of 454 nm/562 nm for 1 (25 µM) with NO-donor 
addition (0 - 150 µM)  
2.4.3. Fluorescence titration with gradual addition of NO-donor under 
anaerobic and aerobic conditions. 
Complex 1 showed stability under aqueous media, 37 °C and pH 7.  Figures 2.5 
and 2.6 show the effects on the fluorescence spectrum of 1 upon titrations with NO, in the 
form of NO-donor MAHMA-NONOate (0-150 µM) dissolved in 0.04 M NaOH, added in   
25 µL portions after 10 minutes intervals, under anaerobic (Figure 2.5) or aerobic (Figure 
2.6) conditions. The emission at 514 nm decreases rapidly upon NO addition and its 
intensity shows linear dependence with NO-donor concentration. The experiment was 
performed under nitrogen atmosphere in order to avoid NO oxidation to N2O3.  
[NO donor] (mM) 
50 
 
 
Figure 2.5 Fluorescence Spectra of 10 µM 1 with NO, acetone/buffer 25:75,                  
λexc = 360 nm, under nitrogen 
 
Quenching of the 514 nm emission, was observed under both anaerobic and 
aerobic conditions. However, under anaerobic conditions (Fig. 2.5) the effect is more 
pronounced, indicating that oxygen is not needed in order for the sensing of NO to take 
place. Such observation is consistent with a mechanism that does not involve O2-
activated intermediates such as NO2 and N2O3, and perhaps implies that sensing is a 
direct result of a reaction of NO with the Re(I) dye. 
 
 
[NO donor] 
0 – 150 µM 
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Figure 2.6 Fluorescence Spectra of 10 µM 1 with NO-donor, acetone/buffer 25:75,  λexc 
= 360 nm 
 
In the comparison plot (Figure 2.7) of I514 from titration spectra under nitrogen 
(Figure 2.5) and under air (Figure 2.6) the consistency of response in aerobic and 
anaerobic conditions is readily observable.  The higher sensitivity for low NO 
concentrations under anaerobic conditions could be attributed to the rapid reaction of NO 
with O2 forming non-reactive oxidized products, such as NO2 and N2O3. 
 
Figure 2.7 Fluorescence Titrations of 1 (10 µM) with NO-donor (0-300 µM), under N2 
vs. under air. I514nm vs. NO-donor concentration. 
[NO donor] 
0 – 150 µM 
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The same comparison for titration of 1 with NO under anaerbic vs. aerobic 
conditions was carried out also after photochemical preparation of the complex. Under 
such conditions the ratiometricity in anaerobic vs. aerobic conditions can be compared. 
Complex 1 prepared photochemically on a 1 mg scale (1.67 mM in THF) showed 
ratiometric response to NO addition at 560 nm (decrease) and at 455 nm (increase). The 
fluorescence spectrum of 1 in THF/acetone/buffer 2/23/75 shows one emission at 562 
nm. The shift in emission compared to the isolated complex could be ascribed both to the 
difference in the solvent system, and the presence of unreacted (phen)Re(CO)3SO3CF3, 
or (phen)Re(CO)2(THF)SO3CF3 which emit at 560 nm and 585 nm respectively (see 
Chapter 3). Figure 2.8 shows the comparison of fluorescence intensity ratio (I454/I562) 
upon titration of 1 with NO, in the form of NO-donor MAHMA-NONOate (0-300 µM) 
dissolved in 0.04 M NaOH in 25 µL portions. The two plots in the graph compare the 
intensity ratios observed under nitrogen and under air. The ratiometric response under N2 
appears more consistent and linear, suggesting that the Re-dye reacts directly with NO 
and not with oxidized products, such as NO2 or N2O3. 
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Figure 2.8 Graph of photochemically substituted (phen)Re(PPh3)(CO)2OSO2CF3 in 
THF 10µM with NO, acetone/buffer 25:75, λexc=360 nm, comparison nitrogen vs air 
 
2.4.4. Fluorescence titration with low concentrations of NO-donor. 
Figure 2.9 shows the fluorescence emission of 1 upon titration with NO, in the 
form of NO-donor MAHMA-NONOate (0 - 150 µM) dissolved in 0.04 M NaOH, added 
in 1 - 25 µL portions after 10 min. intervals, under anaerobic conditions. The 514 nm 
decreases rapidly upon NO addition and emission at 426 nm increases correspondingly 
with NO-donor concentration. The NaCl concentration was lower than in the titration 
experiment described in 2.4.3 and this was found to reduce the intensity of the 514 nm 
emission, but not affecting the intensity of the emerging emission at 426 nm. The 
experiment was performed under nitrogen atmosphere in order to avoid NO oxidation to 
N2O3.  The observed response under anaerobic conditions implies that sensing is a direct 
result of a reaction of NO with the Re(I) dye. 
[NO donor] (mM) 
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Figure 2.9 Fluorescence Spectra of 25 µM 1 (thermally prepared) with NO, 
acetone/buffer 25:75, λexc = 360 nm, under nitrogen. 
 
Figure 2.10 exhibits complex 1 prepared photochemically on a 1 mg scale (1.67 
mM in THF) showed ratiometric response to NO addition at 516 nm (decrease) and at 
436 nm (increase).   
 
Figure 2.10 Fluorescence Spectra of 25 µM 1 (photochemically prepared) with NO, 
acetone/buffer 25:75, λexc = 360 nm, under nitrogen. 
[NO donor] 
0 – 150 µM 
[NO donor] 
0 – 150 µM 
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Figure 2.11 shows the change in fluorescence intensity with increasing NO-donor 
concentration.  As exhibited in Figure 2.7, the intensity of the isolated (thermally 
produced) complex 1 is double than the photochemically produced mixture.   
 
Figure 2.11 Observed fluorescence intensities of 25 µM 1 (thermally prepared) with 
gradual addition of NO-donor, acetone/buffer 25:75, λexc = 360 nm 
 
Figure 2.12 exhibits the comparison of fluorescence intensity ratios when the NO-
donor concentration increases.   The chosen signals were 426 nm and 515 nm for 
complex 1 prepared thermally; and 436 nm and 518 nm for complex 1 parepared 
photochemically.  An important observation after analyzing the ratio of 1 prepared on 
either technique (photochemically or thermally) is the presence of two phenomena, 
higher response at lconcentrations lower than 5 µM of NO-donor than at high ones. 
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Figure 2.12 Observed fluorescence ratio of 25 µM 1 (photochemically and thermally 
prepared) with gradual addition of NO-donor, acetone/buffer 25:75, λexc = 360 nm 
 
2.4.5. FT-IR spectroscopy:  
The FT-IR spectra were collected before (Fig. 2.9) and after the addition of NO-
donor to (phen)Re(PPh3)(CO)2OSO2CF3. After adding NO, the solution was let 
evaporate for 12 hours, for removing acetone, the solids settled down in the tube.  The 
remaining solution was decanted to remove basic impurities, such as MAHMA-
NONOate reaction products and uncoordinated phen and analogs, and the spectrum was 
collected (Fig. 3.10).  In the spectrum of the product after NO addition bands were 
observed at 1739  cm-1, 1660 cm-1 and 1633 cm-1, which are not present in the starting 
material and can be assigned to metal-nitrosyl complexes. These typically show 
stretching bands in the 1600 cm-1 - 1750 cm-1 range.18  Nitroso compounds (organic NO) 
typically appear below 1600 cm-1.  Even though NO stretching bands are typically strong 
they appear rather weak in our spectra, thus indicating that the Nitrosyl complex may not 
be the major product of the reaction of NO with the Re complex, nevertheless the 
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presence of these bands, which do not appear when there is no reaction with NO, are 
indicative of a Re-NO complex.  The typical triflate signals between 1122 cm-1 and 1267 
cm-1 are missing in figure 2.10. 
 
Figure 2.13 FT-IR spectrum of (phen)Re(CO)2(PPh3)OSO2CF3 (1) 
 
 
Figure 2.14 FT-IR spectrum of 2 after reaction with NO-donor. 
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2.4.6. 1H-NMR and 19F-Study of Re complex reactivity: 
 
Figure 2.15 Aromatic region of NMR of 2 before (a) and after (b) reaction with NO-
donor 
 
Figure 2.15 shows the spectrum of (phen)Re(PPh3)(CO)2OSO2CF3 before (Fig. 
2.15a) and after (Fig. 2.15b) reaction with NO-donor. Spectrum 2.15b clearly shows the 
resonances of free triphenylphosphine. Furthermore, experiments performed in identical 
conditions for control compounds (phen)Re(CO)3Cl and (phen)Re(CO)3OTf showed no 
changes after HCl/NaHCO3 washing in the spectrum of (phen)Re(CO)3Cl, while for 
(phen)Re(CO)3OTf, resonances identical to (phen)Re(CO)3Cl were observed, 
presumably because of substitution of triflate with Cl-. These experiments underscore 
the need for a labile L-type ligand, and suggest that triphenylphosphine dissociates for 
NO can react with the metal center. 19F-NMR after NO-donor reaction showed no 
coordinated triflate signals at -78.4 ppm, before or after acid wash.  Thus, it can be 
concluded that CF3SO3- got dissociated after reaction with NO, suggesting that NO 
 a. (phen)Re(PPh3)(CO)2OTf 
 
 
 
 b. (phen)Re(PPh3)(CO)2OTf  after 
reaction with NO-donor 
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displaces both triflate and PPh3 in order to coordinate to Re(I). Such mechanism is 
consistent with the rationale of using Re complexes containing labile L and X ligands 
for NO sensing. 
2.4.7. Cell Studies & Fluorescence Microscopy: 
The solution results and the observed fluorescence responses upon NO addition to 1, 
suggested that these responses could also be observed in cells under aqueous media, 37 C 
and neutral pH. A first step towards applicability of this dye in living cells is to test its 
absorptivity and emission under physiological conditions. 1 was used as an initial model 
of absorptivity into Rat Aortic Endothelial Cells (RAOEC), since it could be readily 
prepared in a solid form and in dilute solutions. 
 
Figure 2.16 Fluorescence response of 2 (10 µM) in RAOEC at λem = 450 nm              
(λexc = 350 nm) showing the absorption of 2 into living cells. 
 
 Figure 2.16 shows that (phen)Re(PPh3)(CO)2OSO2CF3 demonstrated good 
absorptivity into cells via diffusion, in the same fashion that other fluorescent dyes.18 
2.5. CONCLUSION 
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The complex (phen)Re(PPh3)(CO)2OSO2CF3 has been synthesized and 
characterized.  This complex can react with NO under physiological conditions, 
producing a quenching in fluorescence that can be monitored.  This complex has 
permeability through the cell membrane by diffusion and it can be used as fluorescent 
probe for NO oxide imaging.  This is the first example of a rhenium phosphine complex 
used as an NO sensor. 
2.6. REFERENCES 
1. (a) Nagano, T.; Takizawa, H.; Hirobe, M. Tetrahedron Lett. 1995, 36, 8239; (b) 
Nakatsubo, N.; Kojima, H.; Kikuchi, K.; Nagoshi, H.; Hirata, Y.; Maeda, D.; 
Imai, Y.; Irimura, T.; Nagano, T. FEBS Lett. 1998, 427, 263; (c) Kojima, H.; 
Sakurai, K.; Kikuchi, K.; Kawahara, S.; Kirino, Y.; Nagoshi, H.; Hirata, Y.; 
Nagano, T. Chem. Pharm. Bull. 1998, 46, 373; (d) Nakatsubo, N.; Kojima, H.; 
Sakurai, K.; Kikuchi, K.; Nagoshi, H.; Hirata, Y.; Akaike, T.; Maeda, H.; Urano, 
Y.; Higuchi, T.; Nagano, T. Biol. Pharm. Bull. 1998, 21, 1247. 
2. (a) Sun, W. C.; Gee, K. R.; Klaubert, d. H.; Haugland, R. P. J. Org. Chem. 1997, 
62, 6469; (b) Tanaka, K.; Miura, T.; Umezawa, N.; Urano, Y.; Kikuchi, K.; 
Higuchi, T.; Nagano, T.   J. Am. Chem. Soc. 2001, 123, 2530-2536; (c) 
Yamaguchi, K.; Tamura, Z.; Maeda, M. Acta Crystallogr. 1997, C53, 284.  
3. Pluth, M.D.;  Lippard, S.J.  Chem. Commun., 2012, 48, 11981; (b) Lim, M. H,; 
Xu, D.; Lippard, S. J. Nat. Chem. Biol., 2006, 2, 375-380. 
4. (a) Hollis, T. K.; Odenkirk, W.; Robinson, N. P.; Whelan, J.; Bosnich, B. 
Tetrahedron, 1993, 49, 5415; (b) Odenkirk, W.;  Rheingold, A. L.;  Bosnich, B.  
J. Am. Chem. Soc., 1992, 114, 6392; (c) Failer, J. W.;  Ma, Y.;  Smart, C. J.;  
DiVerdi, M. J.  J. Organomet. Chem. 1991, 420, 237; (d) Failer, J. W.; Ma, Y.  J. 
Am. Chem. Soc. 1991, 113, 1579; (e) Honeychuck, R. V.; Bonnesen, P. V.; 
Farahi, J.; Hersh, W. H.;  J. Org. Chem. 1987, 52,  5296; (f)  Bonnesen, P. V.; 
Puckett, C. L.; Honeychuck, R. V.; Hersh, W. H. J. Am. Chem. Soc. 1989, 111, 
6070. 
5. (a) Veghini, D.; Nefedov, S. E.; Schmalle, H.; Berke, H.  J. Organomet. Chem.  
1996, 526, 117-134; (b) Machura, B. Coord. Chem. Rev. 2005, 249, 2277-2307.  
6.  (a) Trovati, A.; Uguagliati, P.  Inorg. Chem. 1971, 10, 851; (b) Wang, Y.; 
Frausto da Silva, J. J. R.; Pombeiro, A. J. L.; Pellinghelli, M. A.; Tiripicchio, A.  
J. Organomet. Chem., 1992, 430, C56; (c) Wang, Y.; Frausto da Silva, J. J. R.; 
Pombeiro, A. J. L.; Pellinghelli, M. A.; Tiripicchio, A.  J. Organomet. Chem. 
61 
 
1994, 476, C9. 
 
7. (a) Batczak, T. J.; Czurak, W.; Dziegielewski, J. O.; Machura, B.; Jankowska, A.; 
Kusz, J.; Warczewski, J.  J. Coord. Chem. 2001, 52, 361; (b) Machura, B.;  
Kruszynski, R.;  Jaworska, M. Polyhedron,  2005, 24, 419; (c) Cameron, T. S.;  
Grundy, K. R.; Robertson, K. N.  Inorg. Chem. 1982, 21, 4149; Chen, J. Y.; 
Grundy, K. R.; Robertson, K. N.  Can. J. Chem. 1989, 67, 1187. 
8. (a) Lees, A. J. Chem. Rev. 1987, 87, 711-743; (b) Stufkens, D. J.; Vlček A. Jr. 
Coord. Chem. Rev. 1998, 177, 127-179; (c) Vlček Jr., A. Coord. Chem. Rev. 
1998, 177, 219-256; (d) Vlcek A. Jr. Coord. Chem. Rev. 2000, 200, 933–977; (e) 
Striplin, D. R.; Crosby, G. A. Chem. Rev. 2001, 211, 163-175; (f) Kumar, A.; 
Sun, S.-S.; Lees, A. J. Top. Organomet. Chem. 2010, 29, 1-35; (g) Wrighton, M. 
S.; Morse, D. L. J. Am. Chem. Soc. 1974, 96, 998-1003; (h) Fredericks, S. M.; 
Luong, J.  C.; Wrighton, M. S. J. Am. Chem. Soc. 1979, 101, 7415-7417; (i) 
Caspar, J. V.; Meyer, T. J. J. Phys. Chem. 1983, 87, 952-957;  (j) Lees, A. J. 
Comments Inorg. Chem. 1995, 17, 319-346;  (k) Baba, A. I.; Shaw, J. R.; Simon, 
J. A.; Thummel, R. H. Schmehl, Coord. Chem. Rev. 1998, 171, 43-59; (l) 
Wallace, D. C. Jackman, R. P.; Rillema, D. P.; Merkert, J. W. Inorg. Chem. 1995, 
34, 5210–5214; (m) Dyer, J.;  Blau, W. J.; Coates, C. G.; Creely, C. M.; Gavey, J. 
D.; George, M. W.; Grills, D. C.; Hudson, S.; Kelly, J. M.; Matousek, P.; 
McGarvey, J. J.; McMaster, J.; Parker, A. W.; Towrie, M.; Weinstein, J. A.; 
Photochem. Photobiol. Sci. 2003, 2, 542-554; (n) Kuimova, M. K.; Sun, Z. P.; 
Matousek, X.; Grills, D. C.; Parker, A. W.; Towrie, M.; George, M. W. 
Photochem. Photobiol. Sci. 2007, 6, 1158-1163. 
9. (a) Fischer, M. J., Jelliss, P. A., Phifer, L. M., and Rath, N. P. Inorg. Chim. Acta 
2005, 358, 1531-1544; (b) Fischer, M. J., Jelliss, P. A., Orlando, J. H., Phifer, L. 
M., and Rath, N. P. J. Lumin. 2005, 114, 60-64; (c) Glezen, M. M. and Lees, A. J. 
J. Am. Chem. Soc. 1988, 110, 3892-3897; (d) Stacy, N. E., Conner, K. A., 
McMillin, D. R., and Walton, R. A. Inorg. Chem. 1986, 25, 3649-3652; (e) 
Loukova, G. V., Huhn, W., Vasiliev, V. P., and Smirnov, V. A. J. Phys. Chem. A 
2007, 111, 4117-4121; (f) Li, C.-K., Cheng, E. C.-C., Zhu, N., and Yam, V. W.-
W. Inorg. Chim. Acta 2005, 358, 4191-4200; (g) Yam, V. W. W., Lam, C. H., 
Fung, W. K. M., and Cheung, K. K. Inorg. Chem. 2001, 40, 3435-3442; (h) 
Kunkely, H. and Vogler, A. J. Photochem. Photobiol. A 2001, 146, 63-66; (i) 
Williams, D. S. and Korolev, A. V. Inorg. Chem. 1998, 37, 3809-3819. 
10. Tsubaki, H., Sekine, A., Ohashi, Y., Koike, k., Takeda, H., Ishitami, O. J. Am. 
Chem. Soc., 2005, 127, 15544-15555 
11. (a) Lee, Y. F. and Kirchhoff, J. R. J. Am. Chem. Soc. 1994, 116, 3599-3600; (b) 
Nakamaru, K. Bull. Chem. Soc. Jpn. 1982, 55, 2697-2705.  
62 
 
12. (a) Geoffroy, G. L.; Wrighton, M. S. Organometallic Photochemistry; Academic 
Press: New York, 1979; (b) Lees, A. J. Chem. Rev. 1987, 87, 711-743. 
13. Kalyanasundaram, K. Photochemistry of Polypyridine and Porphyrin Complexes; 
Academic Press: New York, 1992; Chap. 10, 321-329. 
14. Choi, A. W. T.; Poon, C. S.; Liu, H. W.; Cheng, H. K.; Lo, K.  New J. Chem., 
2013, 37, 1711-1719. 
15. Kavalllieratos, K; Tsoukias, N. M.; Lozano-Lewis, L. I. "Organometallic dyes for 
NO detection and imaging". US Patent 8,906,694B2. Granted: Dec. 9, 2014. 
16. Tsubaki, H., Sekine, A., Ohashi, Y., Koike, k., Takeda, H., Ishitami, O. J. Am. 
Chem. Soc., 2005, 127, 15544-15555 
17.  (a) Pratihar, P.; Dasmahapatra, A. K.; Sinha, C.  Polyhedron, 2007, 26, 1217-
1221. (b) Machura, B.  Coordination Chemistry Reviews, 2005, 249, 2277-2307. 
18. (a) Wright, K. M.; Oparka, K. J. Planta, 1989, 179, 257-64. (b) Achilefu, S. I.; 
Dorshow, R. B.; Bugaj, J. E.; Rajagopalan, R.  Proceedings of the International 
Society for Optical Engineering. 2000, 3917, 80-86. (c) Zhu, H.; Fan, J.; Li, M.; 
Cao, J.; Wang, J.; Peng, X. Chem. Eur. J., 2014, 20, 4691-4696. 
  
63 
 
3. (phen)Re(THF)(CO)2OSO2CF3 AS A FLUORESCENT ORGANOMETALLIC 
COMPLEX NO SENSOR. 
3.1. ABSTRACT 
The complex (phen)Re(THF)(CO)2OSO2CF3 (2) that can be obtained 
photochemically or thermally shows ratiometric response upon NO addition, which was 
added using the  Z-1-N-methyl-N-[6-(N-methylammoniohexyl)amino]diazen-1-ium-1,2-
diolate (MAHMA-NONOate) as an NO-donor. Addition of 5-150 µM of NO-donor into a 
20 µM solution of (phen)Re(THF)(CO)2OSO2CF3 obtained thermally or 
photochemically from (phen)Re(CO)3OSO2CF3 in 25% v/v acetone/phosphate 
saline(PBS) buffer gave fluorescence quenching at 582nm and a concurrent increase in 
emission at 450nm, upon excitation at 360nm. The FT-IR spectroscopy spectrum, upon 
addition of NO-donor, showed bands at 1720 cm-1 and 1631cm-1 that can be ascribed to 
nitrosyl complexes formed upon reaction with NO. Nuclear Magnetic Resonance (NMR) 
studies have shown that the NO fluorescence responses can be ascribed to the reactivity 
of the NO with the organometallic complex.   Fluorescence microscopy studies on Rat 
Aortic Endothelial Cells in 2% v/v acetone/phosphate saline (PBS) buffer using 1 µM of 
2, and 1-10 µM of NO-donor gave notable increases in fluorescence emission at 450 nm 
(λexc = 350nm) and distinct incorporation of the dye into the cell. The system 
demonstrates the potential of a new approach for the design of fluorescent NO sensors 
based on the reactivity and fluorescence changes upon NO coordination to third-row 
transition-metal organometallic fluorescent complexes. 
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3.2. INTRODUCTION 
Nitric oxide has several functions of particular importance for human health.1,2 It 
is now recognized as a key signaling molecule in the cardiovascular system because it 
regulates blood pressure via vasodilation.3  Despite numerous significant scientific 
contributions recently on NO physiology and biomedical functions,4 fundamental 
questions about basic physiological functions of NO remain unclear.5,6  Over the last 
decade, there have been several efforts to model NO-dependent signaling in the 
cardiovascular system7,8,9,10 and controversies regarding the role of NO in the vasculature 
have been discussed.11  Thus, effective quantification and detection of NO in biological 
tissues is of paramount importance in understanding its role and physiology. 
Quantification and imaging of NO in tissues remains a challenge because of the 
absence of a detection method that can combine significant spatial and temporal 
resolution with high NO selectivity12.  Challenges lie in NO’s short lifetime (t1/2 = ca. 5 
s) and the fact that it is found in low concentrations in living tissues.13   
The NO-sensitive fluorescent dyes, such as diaminofluorescein, DAF-FM14 and 
Copper-Fluorescein Cu-FL,15 can provide practical methods for quantification and 
imaging of NO in vitro and in vivo.  Some recent studies16 have reported fluorescent 
probes using different chemical concepts, including what is claimed to be the first 
ratiometric fluorescent probe for NO.16c In a recent report a combined rhodamine-
coumarin fluorophore showed ratiometric sensing for NO, with an fluorescence emission 
increase at 583 nm and a decrease at 473 nm even in cells. 
2,2’-bipy and phenanthroline complexes of Re(I) and Ru(II) have been used as 
fluorescent platforms, and in photoluminescence applications.17 Their favorable 
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photochemical properties, stability of NO complexes,18  and flexibility in accommodating 
conjugated ligand systems offer potent scaffolds for the design of novel NO-selective 
dyes.  Recently Choi and Lo19 have incorporated a diaminopyridine into a Re(phen) 
system to achieve sensing for NO, via the formation of a triazole derivative in the same 
fashion as it has been proposed for the DAF fluorophore reactivity with NO (via initial 
N2O3 formation). They observed an increase of fluorescence emission at 560 nm, yet this 
Re sensor was not found to be responsive at HeLa cells upon NOC-7 NO-donor addition.  
Mascharak and Fry synthesized and tuned ruthenium nitrosyls complexes for targeted NO 
delivery to cells to induce apoptosis.20   
As part of our efforts to explore new mechanisms of NO sensing using fluorescent 
organometallics, we are now demonstrating a concept of NO sensing based on NO 
coordination to a Re(I) center, resulting in a ratiometric response, upon NO addition in 
the form of the NO-donor MAHMA-NONOate. The ratiometric response is dependent on 
NO concentration, and is observed at pH 7.2 in solution (25% v/v acetone/PBS buffer) 
and also in Rat Aortic Endothelial Cells (2% v/v acetone/PBS), by fluorescence 
microscopy. The FT-IR and NMR spectra were consistent with the formation of nitrosyl 
complexes upon reaction of the Re(I)-THF-complex that may be responsible for the 
observed changes in fluorescence.  These new complexes provide a novel concept for 
Nitric Oxide detection in biological tissues that is based on a radically different concept 
that takes advantage of the photophysical properties and synthetic versatility and 
reactivity of the Re(phen)system to give a ratiometric organometallic NO sensor. To our 
knowledge this is the first example of a ratiometric NO sensor that uses coordination of 
NO to a metal center, without a redox reaction at the metal center, and taking advantage 
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of the photophysical properties of phenanthroline complexes of third row transition metal 
organometallics. 
In prior work (Chapter 2), it was shown that (phen)Re(PPh3)(CO)2OSO2CF3, 
prepared thermally or photochemically from  (phen)Re(CO)3OSO2CF3 has the ability to 
react with NO under physiological conditions, producing a fluorescence change at 514 
nm and it has cell membrane permeability. 
3.3. EXPERIMENTAL SECTION 
3.3.1. Material and Methods 
(phen)Re(CO)3Cl and (phen)Re(CO)3OSO2CF3 were prepared as previously 
reported and were found spectroscopically identical  to the reported compounds.21,22 All 
other materials (purchased from Aldrich Chemical Co., ACROS organics, Cayman 
Chemicals, or Alfa Aesar) were standard reagent grade and were used without further 
purification, unless otherwise mentioned.  Tetrahydrofuran (THF) used for the 
preparation of 2, was anhydrous (purchased as an Aldrich Sure-Seal™ product), or 
distilled and dried before use. PBS buffer (0.002 M in total phosphate, pH = 7.2,      
[NaCl] = 0.04 M) was prepared from K2HPO4, KH2PO4, and NaCl (all from Fisher 
Scientific).   Water used for preparation of the buffers and experiments with Nitric oxide 
was filtered water (18 MΩ·cm-1) produced from a Millipore® nanopure diamond lab 
water system (Barnstead Thermolyne Corporation, Dubuque, IA). Deuterated solvents 
were purchased from Cambridge Isotope Laboratories Ltd. Rat Aortic Endothelial Cells 
acquired from Cell Biologics were used for the cell based experiments. Fetal Bovine 
Serum (FBS) and DMSO were bought from ATCC. Penicillin-Streptomycin and 
endothelial cell growth supplement from bovine neural tissue were bought from Sigma 
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Aldrich. DMEM/F-12 medium, Phosphate Buffer Saline (PBS) and Trypsin (0.05% 
EDTA) were bought from Invitrogen Inc. Cell culture flasks and dishes were purchased 
from Fisher Scientific. Photochemical reactions were carried out using a Rayonet 
photochemical reactor (Southern New England Ultraviolet, model RPR-100), equipped 
with a cooling fan and 10 phosphor coated low-pressure mercury lamps (λmax = 300 nm, 
light intensity = 5.2 ± 0.1 × 106 photon/sec/cm3). Fluorescence Spectra were recorded on 
a Jobin Yvon Horiba Fluoromax 3 spectrometer. Fluorescence Microscopy was 
performed using an Olympus IX 81 Fluorescence Microscope and analyzed with IPLab v 
4.04 Scientific Imaging Processing Software.  Frequency-domain fluorescence lifetime 
measurements were performed using a ChronosFD spectrofluorometer (ISS, Champaign, 
IL). Samples were excited with a 370 nm modulated diode, and emission was collected 
using 400 nm long-pass filters (Andover, Salem, NH).  The 1H and 13C NMR spectra 
were recorded on a 400 Bruker NMR spectrometer and were referenced, using the 
residual solvent resonances. All chemical shifts, δ, are reported in ppm.  The FT-IR 
spectra were recorded with a Perkin Elmer Spectrum 100 FT-IR Spectrometer. 
3.3.2. Conversion of (phen)Re(CO)3OSO2CF3 to 
(phen)Re(CO)2(THF)OSO2CF3  
3.3.2.1.Method 1 - Thermal Substitution:  
 (phen)Re(CO)3OSO2CF3 (1 mg, 1.67 µmol) and 1.00 mL of anhydrous 
tetrahydrofurane (final concentration 1.67 mM) were placed in a 10 mL round bottom 
flask, under N2 flow. The solution was refluxed for 48 h.  After refluxing, the color of the 
solution changed from yellow to amber.  This solution was used without further 
treatment.   
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3.3.2.2.Method 2 - Photochemical Substitution: 
 (phen)Re(CO)3OSO2CF3 (1 mg, 1.67 µmol) and 1.00 mL of anhydrous 
tetrahydrofurane (final concentration 1.67 mM) were placed in a NMR tube. The solution 
was irradiated with a Rayonet photochemical reactor (Southern New England Ultraviolet, 
model RPR-100), equipped with a cooling fan and 10 phosphor coated low-pressure 
mercury lamps (λmax = 300 nm, light intensity = 5.2 ± 0.1 × 106 photon/sec/cm3).  After 
irradiation the color of the solution changed from yellow to amber.  This solution was 
used without further treatment. When this procedure was performed in d8-THF, a set of 
signals different from the starting material were observed.  1H-NMR (THF-d8): 7.98 (d, 
2H, 3JH-H = 8.2 Hz, 3JH-H = 5.1 Hz), 8.36 (s, 2H), 8.99 (d, 2H, 3JH-H = 8.28 Hz, 4JH-H = 1.4 
Hz), 9.14 (d, 2H, 3JH-H = 4.7 Hz, 4JH-H = 1.4 Hz). 19F-{1H}-NMR (CDCl3): -78.1 ppm. 
FT-IR (cm-1): 2033 (νCO, vs), 1910 (νCO, vs), 1430, 1290, 1246, 1170, 1031, 848, 725, 
637. UV-Vis (in ethanol): λmax = 360 nm - br (ε = 4500 mol-1cm-1), Fluorescence 
emission in acetone (λexc = 360nm): 585nm Φ1=0.002 (at 370 nm, in 1:3 acetone:PBS, 
using quinine sulfate in sulfuric acid 0.1 M as reference ΦR=0.546).  Lifetime: τ1 = 2.26 
± 0.6 ns,              f1 = 0.114 ± 0.005, α1 = 0.0504; τ2 = 41.3 ± 1 ns, f2 = 0.457 ± 0.01, α2 
= 0.0111; τ3 = 144 ± 6 ns, f3 = 0.436 ± 0.01, α3 = 0.00302.  The presence of 3 lifetimes 
symbolizes three different processes that happen at the same time.  There is an ultrafast 
reaction, it may be a rapid exchange solvent substitution (substitution of THF by water), 
leading to inactivation.  
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3.3.3. Fluorescence studies with addition of NO-donor  
In a typical experiment a THF solution of Re complex prepared as per 2.3.2.1 or 
2.3.2.2. (24 µL, 1.67 mM) is added to 970 µL of acetone to result in 1.000 mL of a 100 
µM solution in 97:3 v/v acetone:THF.  A quantity of 2.75 mL to 3.00 mL of aqueous 
PBS buffer (pH=7.2) was added. Then 0 to 150 µL of 4 mM stock solution of MAHMA-
NONOate NO-donor, in 0.04 M NaOH were added, in order to obtain 75% v/v 
aqueous/organic solution and a final NO-donor concentration from 0 to 150 µM range, 
while to concentration of the Re complex remains constant at 20 µM. No more than 10 
minutes elapsed from preparation of the organic phase to the addition of NO-donor. The 
solution was mixed thoroughly in a vortex and sonicated for 90 min at room temperature.  
The fluorescence of all solutions was measured at λexc= 360 nm and recorded from 400 
nm to 700 nm. For a control experiment a NaOH stock solution was used instead of an 
NO-donor/NaOH stock, in order to account for any possible variations in the 
fluorescence due to pH changes. The result of the control titrations gave identical spectra 
for all titration points for the 1-150 µL range. 
3.3.4. 1H-NMR and 19F-NMR study of reactivity of Re complexes with NO: 
 (phen)Re(THF)(CO)2OSO2CF3 (1 mg), (phen)Re(PPh3)(CO)2OSO2CF3 (1 
mg),23 (phen)Re(CO)3Cl (1 mg), or (phen)Re(CO)3OSO2CF3 (1 mg) were added to 0.05 
mL of THF in four separate 10 mL vials.  1.6 mL of acetone was added.   Then 2.4 mL of 
PBS aqueous buffer (pH = 7.2) and 0.2 mL of stock NO-donor solution 5 mM in 0.04 M 
NaOH were added sequentially.  The mixtures were vortexed for 30 sec and then 
sonicated for 3h at room temperature. Dichloromethane was added (3 x 10 mL), and the 
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organic layer was dried with anhydrous sodium sulfate.  The solvent was evaporated and 
the non-volatiles were taken up in chloroform and the NMR spectra were collected.   In 
order to remove uncomplexed phenanthroline products and collect only the NMR of 
complexes  the organic phases were further diluted with dichloromethane and washed 
with 1 M hydrochloric acid, followed by 1 M sodium bicarbonate, rinsed with deionized 
water, and dried with anhydrous sodium sulfate.  The volatiles were evaporated, the solid 
residues were redissolved in chloroform-d, and the NMR spectra were collected.   These 
experiments were also performed under identical conditions for control compounds 
(phen)Re(CO)3Cl and (phen)Re(CO)3OTf. After HCl/NaHCO3 washing no changes were 
observed in the 1H-NMR spectrum of (phen)Re(CO)3Cl, while for (phen)Re(CO)3OTf, 
resonances identical to (phen)Re(CO)3Cl were observed. 
3.3.5. Fluorescence microscopy studies of addition of NO-donor to 
(phen)Re(THF)(CO)2OSO2CF3 in Rat Aortic Endothelial Cells: 
Cell preparation: Rat Aortic Endothelial Cells were grown in Dublecco’s Modified Eagle 
Medium: Nutrient Mixture F-12 medium (DMEM/F-12) supplemented with 10% Fetal 
Bovine Serum (FBS), 1% penicillin-streptomycin, and endothelial cell growth 
supplement in a humidified tissue culture incubator at 37oC equilibrated with 95/5 v/v% 
Air/CO2 mixture. Cells were cultured in 35 × 10 mm dishes seeded with 2 × 105 cells and 
used at 60-80% confluency. 
Solution Preparation: A 500 µM solution of Re(phen)(THF)(CO)2OSO3CF3 in 
THF/acetone (Solution B) was prepared from 62.5 µL of a stock solution of 
Re(phen)(THF)(CO)2OSO3CF3 in THF (1.6 x 10-3 M - Solution A) and 138 µL of 
acetone.  This solution was added to 800 µL of 10 mM PBS buffer solution (pH=7.2), 
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resulting in a final 100 µM solution of 1 in 80/14/6 v/v aqueous buffer/acetone/THF. This 
new solution was further diluted 1/10 v/v with PBS Buffer before adding it to the cells, 
resulting in a final solution of 10 µM of 1 in 98/1.4/0.6 v/v aqueous PBS 
buffer/acetone/THF (Solution C). Various quantities of 6 mM NO-donor solution 
(MAHMA-NONOate) in 0.01M NaOH were diluted with 0.01M NaOH to give 0, 100, 
500 & 1000 µM solutions of NO-donor (Solutions D-G).   
Loading of solution C (10 µM of Re complex 1):  The old media was poured out from the 
plates; then the plates were rinsed twice with 1 mL of 10 mM PBS (pH = 7.2). Then 100 
µL of DMEM/FBS/Penicillin Media, 800 µL of PBS 10 mM, and 100 µL of Re complex 
stock (Solution C) were added with this specific order. The plates were incubated for 75 
min. at 37 oC equilibrated with 95/5 v/v% Air/CO2 mixture. 
Loading of NO-donor: First the reactive media was poured out from the plate; then the 
plates were rinsed twice with 1 mL of 10 mM PBS (pH = 7.2). Then 100 µL of 
DMEM/FBS/Penicillin Media, 890 µL of PBS 10 mM, and 10 µL of NO-donor solution 
in NaOH from 0-1000 µM range (Solutions D-G) were added to give final NO-donor 
concentrations of 0 µM, 1 µM, 5 µM, and 10 µM. The plates were incubated for 15 min; 
the reactive media was poured out from the plate, and 1 mL of fresh PBS 10 mM was 
added to each plate. 
Fluorescence Microscopy Measurements:  Each plate was placed in the fluorescence 
microscope and measured under a filter an excitation wavelength of 350 nm (330-380 nm 
window) and an emission window of 440-460 nm.  The images were collected with a 
total exposition time of 2668 ms and 20X zoom. 
72 
 
 
3.4. RESULTS AND DISCUSSION 
3.4.1. Design Considerations 
To achieve our goal of obtaining a ratiometric fluorescent probe that can detect 
changes in NO concentration with high sensitivity and selectivity, we are using an 
entirely new approach for NO sensing that combines the following elements: 1) NO 
binding to a Re(I) metal center, 2) a phenanthroline, attached on the metal, which 
provides favorable photophysical characteristics,17 as well potential for modification, for 
fine-tuning the emission wavelength, and 3) a labile ligand (THF or OSO2CF3) which is 
expected to be displaced by NO altering the fluorescence emission upon NO addition.  
NO coordination to the Re center is expected to shift the MLCT band to higher 
frequency, since NO is a π-acceptor, unlike THF that is a donor. 
 
Scheme 3.1 Concept diagram for phenanthroline-rhenium NO sensors 
3.4.2. Fluorescence  Studies: 
Solutions of (phen)Re(THF)(CO)2OSO3CF3 prepared photochemically or 
thermally were let to react with NO-donor in PBS buffer, without prior isolation of these 
species. Absorption Spectra of (phen)Re(THF)(CO)2OSO2CF3 in methanol and 
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fluorescence spectra of solutions of (phen)Re(THF)(CO)2OSO2CF3 in acetone show 
characteristic differences from the spectra of the triflate complex with a single intense 
fluorescence emission at 585 nm. However in the presence of water, such as in PBS 
buffer before addition of NO-donor, there is also a weak emission at 435 nm, which 
could be ascribed to decomposition species. An NMR study of the conversion of the 
triflate complex to 1 showed clearly the resonances of a new complex consistent with the 
formulation presented and the THF and triflate in a trans- configuration. For the isolated 
triphenylphosphine analog 2, a single emission at 514 nm is observed.  
For complex 1 prepared photochemically as soon as NO-donor was added to the 
solution, (10 μM to 250 μM concentration range) the emission intensity at 585 nm 
decreased while the emission intensity at 435 nm increased and its maximum was shifted 
to 445 nm (Figures 3.1 and 3.2). However, it appears to be an anomaly for the 10 µM and 
20 µM points, (Figure 3.2), since the trend is opposite for small additions of NO-
donor/NaOH solution. This could be ascribed to the fact that the zero point does not have 
any NaOH. Similar results were observed when the complex was prepared thermally 
(Figure 3). The emission at 585 nm appears to be quenching before the increase of the 
emission at 445 nm becomes prominent. This may be indicative of a two-step process, 
with a first step that may involve the partial dissociation of the THF ligand followed by 
radiation-less radical reactions, and a second step forming a species with a fluorescence 
emission at 445 nm. As a control, experiments with (phen)Re(CO)3Cl and 
(phen)Re(CO)3OSO2CF3 under identical conditions showed no changes in the 
fluorescence spectra.   
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Figure 3.1 Fluorescence Response upon NO-donor addition (0-150 µM) to 20 µM of 
Re complex 2 (generated by photochemical substitution) in acetone/PBS aqueous 
buffer 25/75 v/v, (λexc = 360 nm) 
 
 
Figure 3.2 Observed Fluorescence intensities λmax = 450nm and λmax = 582 nm upon 
NO-donor addition [2] = 40 µM (λexc=360 nm).  
 
[NO donor] (mM) 
[NO donor] 
0 – 150 µM 
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Figure 3.3 Fluorescence Response upon NO-donor addition (0-150 µM) to 20 µM of 
Re complex 2 (generated by thermal substitution) in acetone/PBS aqueous buffer 
25/75 v/v, (λexc=360 nm)  
 
Having similar results but not identical suggest that the degree of conversion may 
vary between the two methods but the identity of the final product is the same.  A blank 
experiment was performed using only gradual increasing amounts of sodium hydroxide 
solution in absence of MAHMA NONOate; in the outcome there was no reaction at all, 
this confirm that it is the reaction with NO-donor the responsible of the change in 
fluorescence. 
Fluorescence titration with gradual addition of NO-donor under anaerobic and aerobic 
conditions: For fluorescence titration measurements, a stock solution of 
(phen)Re(CO)3OSO2CF3 in THF with a mass concentration of 1 mg/mL was freshly 
prepared and  irradiated at 300 nm in a 10 lamp photoreactor for 75 minutes, obtaining a 
solution of the complex. Then,  67 μL of this stock solution was diluted in 683 μL of 
acetone and 2250 μL of phosphate buffer 0.002 M pH 7.2 with sodium chloride 0.04 M 
[NO donor] 
0 – 150 µM 
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(resulting in a total volume of 3 mL and a final mass concentration of 25 μM) in a quartz 
glass cuvette.   The fluorescence emission was monitored using λexc of 360 nm. The 
bandpass for excitation and emission was 2 nm.   A stock solution of MAHMA NONOate 
in NaOH 0.04M with a mass concentration of 3 mmol/mL was freshly prepared; this 
stock solution was dispensed stepwise in portions of 25 μL from a 50 μL syringe into the 
fluorescence cuvette. After each step, the solution was left react for 10 minutes 
(approximately, 3 MAHMA NONOate half-life) of at room temperature before 
measuring fluorescence using the same parameters as above. 
In another cuvette, it was prepared other 3000 µL of 
(phen)Re(THF)(CO)2OSO2CF3  in the same THF/acetone/buffer (see above) was 
bubbled with nitrogen for 30 minutes.  The fluorescence titration was performed under 
the same conditions than above. 
  
Figure 3.4 Fluorescence Spectra of 2 25µM with NO, acetone/buffer 
25:75, λexc=360 nm, under nitrogen 
 
[NO donor] 
0 – 150 µM 
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Figure 3.5 Fluorescence Spectra of 2 25µM with NO, acetone/buffer 
25:75, λexc=360 nm 
 
The results were as expected, quenching signal at 585 nm versus a slight 
increment in the signal around 430nm.   After performing the titration under air or under 
nitrogen exhibiting similar behaviors, it can be concluded that it is no need to an oxidant 
environment in order the reaction to occur; like in the triazol formation based dyes.  On 
the same tenor, it can be concluded that NO is the real substrate. 
The intensity of the titration performed under air is 40% lower than under 
nitrogen, and the response towards NO addition is lower in the same extend, that can be 
explained by oxidation of the real substrate NO to NO2, and this second one cannot be 
used as a substrate for this Re complex. 
One noticeable result is that in both cases the increment in the 430 nm signal is 
the same in both cases.  It can be concluded that this signal depends only on the product 
after addition of NO; and no on the side reaction of the starting material. 
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Figure 3.6 Fluorescence Spectra of (phen)Re(THF)(CO)2OSO2CF3/THF  30µM with 
NO, acetone/buffer 25:75, λexc = 360 nm, comparison nitrogen vs air 
 
 
Figure 3.7 Fluorescence intensity ratio of 430 nm/578 nm for 2(25 µM) with NO-
donor addition (0 - 150 µM) 
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There was a linear response at the lower range; until 3 times 
(phen)Re(THF)(CO)2OSO2CF3 complex concentration was reached; saturation was not 
reached. 
3.4.3. FT-IR spectroscopy:  
The FT-IR spectra were collected before (Fig. 3.8) and after the addition of NO-
donor to 1. After adding NO, the solutions were treated by an acid/base wash (1 M HCl / 
1 M NaHCO3 in order to remove basic impurities, such as MAHMA-NONOate reaction 
products and uncoordinated phen and analogs, and the spectrum was collected (Fig. 3.9).  
In the spectrum of the product after NO addition bands were observed at 1720 cm-1 and 
1631 cm-1, which are not present in the starting material and can be assigned to metal-
nitrosyl complexes. These typically show stretching bands in the 1600 cm-1 - 1750 cm-1 
range.18c,18d  Nitroso compounds (organic NO) typically appear below 1600 cm-1.  Even 
though NO stretching bands are typically strong they appear rather weak in our spectra, 
thus indicating that the Nitrosyl complex may not be the major product of the reaction of 
NO with the Re complex, nevertheless the presence of these bands, which do not appear 
when there is not reaction with NO, are indicative of a Re-NO complex.  
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Figure 3.8 FT-IR spectrum of 2  
 
Figure 3.9 FT-IR spectrum of 2 after reaction with NO-donor and wash with 1 M 
HCl/1 M NaHCO3.  
 
 
 
 
 
 
 
81 
 
3.4.4. 1H-NMR and 19F-NMR Study of Re complex reactivity: 
Formation of 1 from (phen)Re(CO)3(OSO2CF3) in d8-THF:  
Photosubstitution of (phen)Re(CO)3OSO2CF3 in d8-THF allowed monitoring of 
conversion into complex 1 by NMR spectroscopy (Fig. 2.10). Two different species (A 
and B) can be identified in the spectrum with integration of ratios of 80/20 after 30 min, 
while  a third species (C) appears after 90 min with an integration ratio of 7 to 62(for A) 
to 32 (For B). These three species are presumed to be the starting material (A), and the 
trans-THF/triflate cis-CO complex (B), and the cis-THF/triflate cis-CO complex (C). The 
assignments are based on the higher observed symmetry of the spectral pattern for B.  
 
Figure 3.10 Aromatic region of 1H-NMR spectra (d8-THF) for 2 (top), 2 after 30 min of 
UV irradiation at 300 nm (middle), and after 90 min of UV irradiation (bottom). 
 
Even before the reaction mixture was irradiated there was a small conversion to 
the trans-THF-triflate complex (Fig. 3.10a).  The isolated and spectroscopically 
(phen)Re(CO)
3
OTf / d8-THF 
a. Before photosubstitution 
 
 
 
 
b. After 30 minutes of 
photosubstitution 
 
 
 
c. After 90 minutes of 
photosubstitution 
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characterized phosphine analog 1, (Chapter 2), which is in the trans PPh3-triflate 
configuration was found to have analogous spectroscopic symmetric splitting pattern with 
the major product of the reaction in d8-THF assigned as trans- (Species B).  
NMR study of reactivity of rhenium complexes with NO:  The 1H-NMR spectra of 
(phen)Re(CO)3Cl and phenanthroline do not show spectral changes under irradiation 
conditions with THF, and futhermore no spectroscopic changes are observed even after 
the addition of NO-donor to the irradiated solutions. The triflate complex however 
showed some spectral changes upon reaction with 20-fold excess of NO donor (or 
40-fold excess of NO as each MAHMA-NONOate gives 2 NO molecules which can be 
compared with the NMR spectra of complexes 1 and 2 under the same conditions(Figure 
3.11a).  
 
Figure 3.11 Aromatic region of 1H-NMR spectra after reaction with NO-donor (d8-THF) 
of (a) (phen)Re(CO)3OSO2CF3, (b): 1 (c): 2.  
a. (phen)Re(CO)3OTf with NO-donor 
 
 
b. (phen)Re(PPh3)(CO)2OTf with NO-donor 
 
 
 
c. (phen)Re(THF)(CO)2OTf with NO-donor 
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The spectrum of (phen)Re(CO)3OSO2CF3 upon reaction with NO shows two sets 
of phenanthroline signals (4 signals), and the appearance of a new set of signals at δ 7.4 
and 7.8 ppm (Figure 3.11a).  For the phosphine complex the integration between the two 
sets of signals (products vs. starting material) shows higher ratio of products vs. starting 
material,  with an additional set of signals overlapping with the triphenylphosphine signal 
(Fig. 3.11b). The integration ratios and chemical shift changes indicate triphenylphospine 
dissociation. Phenanthroline is also dissociated upon NO reaction and phenanthroline-
containing byproducts are formed.  For the THF complex 2, the signals from the starting 
material are completely consumed; signals at δ = 7.4 and 7.8 ppm are the most intense 
and those signals do not exhibit phenanthroline splitting pattern. Integration of THF 
resonances in the 1.8 - 2.8 ppm region also indicate THF dissociation from Re upon 
reaction with NO.  
Acid/Base wash studies:   Phenanthrolines and substituted phenanthrolines, which are not 
bound to the rhenium center, are basic and can be removed (together with the amines 
formed as byproducts from reaction of MAHMA NONOate) by acid wash with 1.0 M 
HCl, (Fig. 3.12).23 After 2 reacts with NO-donor (5-fold excess) it displays a complicated 
spectrum, (Fig. 3.12a) caused by the presence of six different species, of which only two 
appear to contain Re. After treatment with 1M HCl, and then 1M NaHCO3, the basic 
organic species are removed, and only the Re-containing species remain in the spectrum.  
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Figure 3.12 NMR spectra (aromatic region) for the reaction of 2 with NO-donor before 
(a) and after (b) wash with 1M HCl / 1M NaHCO3. 
 
One of the species present is (phen)Re(CO)3Cl, possibly formed after reaction of 
the coordinatively unsaturated Re(I) center resulting after dissociation of THF and 
OSO2CF3- ligands. The chemical shifts of the second species are completely different 
from complex 2 and are consistent with a species that has no longer contains a 
coordinated CF3SO3- ligand and in which the THF has been replaced by a π-acid such as 
NO.   In summary, with the exception of (phen)Re(CO)3Cl, all the NMR spectra show a 
pattern of a) signals corresponding to non-coordinated to Re ortho-di-substituted 
phenanthroline which practically disappear after  treatment with 1M HCl / 1M NaHCO3 
b) signals corresponding to possibly a Re nitrosyl complex (or complexes) and c) signals 
corresponding to (phen)Re(CO)3Cl presumably formed from unreacted 
(phen)Re(CO)3OSO2CF3.  The intensity patterns for those peaks indicate a decrease in 
reactivity moving from 2, to 1, to (phen)Re(CO)3OSO2CF3. 
a. (phen)Re(THF)(CO)2OTf after 
react with NO-donor; before 
acid/base wash 
 
 
b. (phen)Re(THF)(CO)2OTf after 
react with NO-donor; after 
acid/base wash 
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These experiments underscore the need for a labile L-type ligand, and suggest 
that triphenylphosphine dissociates in order for NO to react with the metal center. 19F-
NMR after NO-donor reaction showed no coordinated triflate signals at -78.4 ppm, 
before or after acid wash.  Thus, it can be concluded that CF3SO3- got dissociated after 
reaction with NO, suggesting that NO displaces both triflate and PPh3 in order to 
coordinate to Re(I). 
3.4.5. Cell Studies & Fluorescence Microscopy: 
 Fluorescent dyes should be able to detect NO in biological systems, such as cells 
and endothelial tissues, in order to be practical for NO imaging and study of mechanistic 
aspects of its physiology.   
Reactivity of 2 in RAOEC:  Fluorescent dyes should be able to give a visible fluorescence 
response to different intracellular NO concentrations.  Fig 3.13 shows that increasing the 
concentration of NO leads to increases in fluorescence intensity.  Beyond 10 µM NO, the 
RAOEC cells showed signs of shrinking, indicative of cell death. 
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Figure 3.13 Picture sequence demonstrating fluorescence response in RAOEC at λem = 
450 nm, Dye was generated by photochemical substitution (50 min). (a) with no NO-
donor added (b) with 1 µM NO-donor (c) with 5 µM NO-donor and (d) with 10 µM NO-
donor. λexc = 350 nm. 
 
The reaction of rhenium complexes with NO-donor is complex and produces 
several species, some of them fluorescent. Both the NMR and fluorescence studies are 
consistent with an initial dissociation of the labile THF or PPh3 ligand, followed by 
reaction with NO either i) on the coordinated phenanthroline with subsequent 
dissociation from the metal center, as it has been observed before by Hill25, Mann26 and 
Halper27 or ii) on the Re center forming a nitrosyl complex. The presence of CFSO3- in 
the Re coordination sphere is important for reaction with NO.  Scheme 2 summarizes 
possible mechanistic pathways: 
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Scheme 3.2 Proposed mechanistic pathways for NO reactivity with 
(phen)Re(CO)2(THF)OSO2CF3  (2) 
 
3.5. CONCLUSIONS  
The organometallic Re(I) complex was shown to  react with NO at room 
temperature, producing fluorescence responses.  The presence of labile ligands (THF, 
triflate, PPh3) is critical for reactivity with NO. Comparison studies show that rhenium 
complexes are prone to partial deactivation by side-reactions. These probes are able to 
permeate the cell membrane by diffusion and also exhibit fluorescence responses upon 
NO-donor addition inside the cell. 
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4.   STUDY OF THE FLUORESCENT ORGANOMETALLIC COMPLEX 
(phen)Re(CH3CN)(CO)2OSO2CF3  AS A NO SENSOR. 
4.1 ABSTRACT 
 The complex (phen)Re(CH3CN)(CO)2OSO2CF3 (3), which can be obtained 
thermally from (phen)Re(CO)3OSO2CF3 shows fluorescence quenching response upon 
NO addition, which was added in the form of NO-donor Z-1-N-methyl-N-[6-(N-
methylammoniohexyl)amino]diazen-1-ium-1,2-diolate (MAHMA-NONOate). Addition 
of 10-150 µM of NO-donor into a 25 µM solution of (phen)Re(CH3CN)(CO)2OSO2CF3 
in 25% v/v acetone/phosphate saline (PBS) buffer gave fluorescence quenching at 532 
nm, upon excitation at 360 nm. The 1H-NMR and 19F-NMR spectra after reaction with 
NO showed characteristic resonances for non-coordinated triflate and CH3CN, 
suggesting that the organometallic product formed upon NO releases both these ligands 
upon reaction with NO.   The present study expands our newly demonstrated approach 
for the design of fluorescent NO sensors based on NO coordination to Re;1 3 is an 
isolable complex, which is stable at room temperature and therefore can be used as an 
NO sensing organometallic dye, as prepared, without further treatment. 
4.2 INTRODUCTION 
Acetonitrile transition metal complexes have been used as intermediaries in 
inorganic and organometallic synthesis.2   These complexes are stable at room 
temperature and react only under photochemical conditions or at high temperatures.3   
Rhenium acetonitrile complexes are typically synthesized by reflux in acetonitrile4 or 
using trimethylamine N-oxide dehydrate.5  
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Rhenium tricarbonyl complexes have interesting photophysical properties, and 
they are used as luminophores.6   Rhenium imaging probes have shown reliable responses.   
Changing fluorophores selectively may target different subcellular structures.  
Rhenium(I) reacts with specific biochemical agents localized in the cell, such as sulfur-
containing aminoacids in the mitochondria.7  
In prior work (Chapters 2 and 3), it was shown that 
(phen)Re(THF)(CO)2OSO2CF3, and (phen)Re(PPh3)(CO)2OSO2CF3  prepared in situ 
thermally or photochemically from (phen)Re(CO)3OSO2CF3 have the ability to react 
with NO under physiological conditions, producing a fluorescence change. The new 
acetonitrile analog 3 introduced in this Chapter shows analogous fluorescence responses, 
that can be ascribed directly to NO complexation by Re, as indicated by NMR and IR 
spectroscopic studies. 3 also has the additional advantages that it can be prepared in an 
isolable form, and is stable at room temperature. 
4.3 EXPERIMENTAL SECTION 
4.3.1. Materials and Methods 
The complexes (phen)Re(CO)3Cl and (phen)Re(CO)3OSO2CF3 were prepared as 
previously reported and were found spectroscopically identical  to the reported 
compounds.8,9 All other materials (purchased from Aldrich Chemical Co., ACROS 
organics, Cayman Chemicals, or Alfa Aesar) were standard reagent grade and were used 
without further purification, unless otherwise noted.  PBS buffer (0.002 M in total 
phosphate, pH = 7.2,  [NaCl] = 0.04 M) was prepared from K2HPO4, KH2PO4, and NaCl 
(all from Fisher Scientific).  Water used for preparation of the buffers and experiments 
with Nitric oxide was filtered water (18 MΩ·cm-1) produced from a Millipore® nanopure 
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diamond lab water system (Barnstead Thermolyne Corporation, Dubuque, IA). 
Deuterated solvents were purchased from Cambridge Isotope Laboratories Ltd.  1H 
and 13C NMR spectra were recorded on a 400 Bruker NMR spectrometer and were 
referenced, using the residual solvent resonances. All chemical shifts, δ, are reported in 
ppm.  FT-IR spectra were recorded with a Perkin Elmer Spectrum 100 FT-IR 
Spectrometer.  Frequency-domain fluorescence lifetime measurements were performed 
using a ChronosFD spectrofluorometer (ISS, Champaign, IL). Samples were excited with 
a 370 nm modulated diode, and emission was collected using 400 nm long-pass filters 
(Andover, Salem, NH).   
4.3.2. Synthesis of (phen)Re(CH3CN)(CO)2OSO2CF3:  
20.0 mg of (phen)Re(CO)3OSO2CF3 (33.3 µmol) and 20 mL of acetonitrile (final 
concentration: 16.5 mM) were placed in a 50 mL round bottom flask under N2 flow. The 
solution was refluxed for 48 hours.  The color changed during reflux from yellow to 
amber.  The volatiles were reduced to 1.0 mL. The product was precipitated at room 
temperature by adding 4.0 mL of diethyl ether.  The bright yellow powder product was 
filtered and was dried in vacuo at 40 oC.  18.4 mg, (84%). 1H-NMR (CDCl3): 2.18 (3H, 
s), 8.04 (d, 2H, 3JH-H = 8.3 Hz, 3JH-H = 5.1 Hz), 8.20 (s, 2H), 8.79 (d, 2H, 3JH-H = 8.3 
Hz, 3JH-H = 1.3 Hz), 9.37 (d, 2H, 3JH-H = 5.1 Hz, 3JH-H = 1.2 Hz). 13C-{1H}-NMR 
((CD3)2CO): 3.17 (CH3CN, s, 1C), 127.93 (CH, s, 2C), 129.11 (CH, s, 2C), 132.27 (CH, 
s, 2C), 147.84 (CN, s, 1C), 155.74 (CH, s, 2C).  19F-{1H}-NMR (CDCl3): -78.2 ppm.  
FT-IR (cm-1): 2295 (νCN, w), 2033 (νCO, s), 1927 (νCO, s), 1904 (νCO, s), 1631, 1521, 
1431, 1417, 1255, 1222, 1156, 1030, 877, 851, 724, 637. UV-Vis (in ethanol): λmax = 360 
nm - br (ε = 1840 mol-1cm-1), Fluorescence emission in acetone (λexc = 360nm): 532 nm 
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Φ1=0.006 (at 370 nm, in 1:3 acetone/PBS buffer, using quinine sulfate in sulfuric acid 
0.1 M as reference ΦR=0.546).  Lifetime: τ1 = 15.1 ± 0.4 ns, f1 = 0.257 ± 0.004, α1 = 
0.017; τ2 = 141 ± 3 ns, f2 = 0.424 ± 0.003, α2 = 0.00301.  There are two major processes 
occurring.  The adding contributions only add up 70%.  There are minor reactions not 
fully described. 
4.3.3. Fluorescence experiments with NO-donor  
In a typical experiment, a 100 µM solution of (phen)Re(CH3CN)(CO)2OSO2CF3 
complex was prepared from 1.67 mM stock solution of 
(phen)Re(CH3CN)(CO)2OSO2CF3  in THF and acetone was added up to 1.000 mL of 
total solution of Re complex.  2.75 mL to 3.00 mL of aqueous PBS buffer (pH = 7.2) was 
added. Then 0 to 250 µL of 4 mM stock solution of MAHMA-NONOate NO-donor, in 
0.04 M NaOH, were added in order to obtain 75% v/v aqueous/organic solution and a 
final NO-donor concentration from 0 to 200 µM range, while the concentration of Re 
complex remained constant at 25 µM. No more than 10 minutes elapsed from preparation 
of the organic phase to the addition of the NO-donor. The solution was mixed thoroughly 
in a vortex and sonicated for 90 minutes at room temperature.  The fluorescence of all 
solutions was measured with a λexc = 360 nm and the emission was recorded from         
400 nm to 700 nm.  For a control experiment, a NaOH solution was used instead of an 
NO-donor/NaOH stock solution in order to account for any possible variations in the 
fluorescence due to minor pH changes. The result of the control titrations gave identical 
spectra for all titration points for the 1-150 µL range. 
 
94 
 
 
4.3.4. Fluorescence titration with gradual addition of NO-donor under 
anaerobic and aerobic conditions.  
In a typical experiment, a 200 µM of solution of 
(phen)Re(CH3CN)(CO)2OSO2CF3 complex was prepared from 1.67 mM stock solution 
in acetone up to 0.750 mL of total solution of Re complex.   2.25 mL of aqueous PBS 
buffer (pH=7.2) was added. The fluorescence emission was monitored using λexc = 360 
nm. Then, 3 mM stock solution of MAHMA-NONOate NO-donor in 0.04 M NaOH was 
added progressively in 25 µL portions up to the total of 300 µL.  After each addition, the 
solution was left to react for 10 minutes (approximately 3 MAHMA NONOate half-lives) 
at room temperature before measuring fluorescence using the same parameters as above 
mentioned.   
In another cuvette, another 3000 µL of (phen)Re(CH3CN)(CO)2OSO2CF3 was 
prepared in the same acetone/buffer system (see above); this solution was bubbled with 
nitrogen for 30 minutes.  The fluorescence titration was performed under the same 
conditions mentioned above. 
4.4. RESULTS 
4.4.1. Synthesis of (phen)Re(CH3CN)(CO)2OSO2CF3 (3) 
Complex 3 was synthesized by thermal substitution of CO from 
(phen)Re(CO)3SO3CF3.  The isolated product was characterized by 1H and 13C-NMR 
and FT-IR. 
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Scheme 4.1 Synthesis of (phen)Re(CH3CN)(CO)2OSO2CF3 (3) 
4.4.2. Fluorescence studies with addition of NO-donor  
Complex 3 showed significant fluorescence response to NO addition. The 
fluorescence spectrum of 3 in acetone/buffer 25/75 v/v shows one emission at 565 nm  
(Φ = 0.006). Figure 4.1 shows the effects on the fluorescence spectrum of 3 upon NO 
gradual addition, in the form of NO-donor MAHMA-NONOate (0-150µM) dissolved in 
0.04 M NaOH. The emission at 562 nm decreases rapidly upon NO addition and its 
intensity shows linear dependence with NO-donor concentration, thus allowing NO 
quantification in the 0-150 µM range (Figure 4.1). 
 
Figure 4.1 Fluorescence Response upon NO-donor addition (0-150 µM) to 20 µM of 
Re complex 3 in acetone/PBS aqueous buffer 25/75 v/v, (λexc = 360 nm) 
 
[NO donor] 
0 – 150 µM 
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4.4.3. Fluorescence titration with gradual addition of NO-donor under 
anaerobic and aerobic conditions. 
Complex 3 showed significant stability under physiological conditions.  Figure 
4.2 shows the effects on the fluorescence spectrum of 3 upon NO consecutive addition, in 
the form of NO-donor MAHMA-NONOate (0 – 300 µM) dissolved in 0.04 M NaOH, in   
25 µL portions after 10 minutes intervals. The emission at 532 nm decreases rapidly upon 
NO addition and its intensity shows linear dependence with NO-donor concentration, this 
experiment was performed under nitrogen to avoid NO oxidation to N2O3, in a titration 
fashion.  
 
Figure 4.2. Fluorescence Spectra of 50 µM 3 with NO, acetone/buffer 25:75,   
λexc = 360 nm, under nitrogen 
 
Figure 4.3 shows the effects on the fluorescence spectrum of 1 upon NO 
consecutive addition, in the form of NO-donor MAHMA-NONOate (0 - 300µM) 
dissolved in 0.04 M NaOH, in 25 µL portions after 10 minutes intervals. The emission at 
532 nm decreases rapidly upon NO addition and its intensity shows linear dependence 
[NO donor] 
0 – 150 µM 
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with NO-donor concentration, this experiment was performed under air, in a titration 
fashion; some NO got consumed by oxidation. The intensity of the titration performed 
under air is 30% lower than under nitrogen, as exhibit in Figure 4.3; and the response 
towards NO addition is lower in the same extend, that can be explained by oxidation of 
the real substrate NO to NO2, and this second one cannot be used as a substrate for this 
Re complex. 
 
 Figure 4.3. Fluorescence Spectra of 50 µM 6 with NO, acetone/buffer 25:75,   
λexc = 360 nm 
 
The fluorescence titration comparison plot (Figure 4.4) of I532 vs [NO-donor] 
under nitrogen (Figure 4.2) and under air (Figure 4.3) shows the similarity of responses in 
the two experiments, and also higher sensitivity in lower concentrations of NO under 
anaerobic conditions. Thus, it can be concluded that there is no need for an oxidant in 
order for the reaction to occur.  This result is indicative of direct interaction of the dye 
with NO and not with NO-derived oxidized products. 
[NO donor] 
0 – 150 µM 
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19F-NMR after NO-donor reaction showed no signals.  It can be concluded that 
CF3SO3- got dissociated after reaction with NO; this proves one part of the mechanism. 
 
Figure 4.4 Fluorescence Spectra of 3 50µM with NO, comparison nitrogen vs air at    
532 nm. 
 
4.4 CONCLUSION 
 The new complex (phen)Re(CH3CN)(CO)2OSO2CF3 has been synthesized and 
characterized.  This complex can react with NO under physiological conditions, 
producing a quenching in fluorescence that can be monitored.   
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5. α-DIIMINE RHENIUM COMPLEXES, AS COLORIMETRIC SENSORS FOR 
NO and CN-. 
5.1. ABSTRACT 
The complexes (Xy-DAD)Re(THF)(CO)2OTf (8), (Xy-
DAD)Re(CH3CN)(CO)2OTf (9),   (iPr-DAD)Re(THF)(CO)2OTf (10), and (iPr-
DAD)Re(CH3CN)(CO)2OTf (11) obtained photochemically from (Xy-
DAD)Re(CO)3OTf (5) and (iPr-DAD)Re(CO)3OTf (7) respectively show colorimetric 
response upon NO and CN- addition, which was added in the form of NO-donor Z-1-N-
methyl-N-[6-(N-methylammoniohexyl)amino]diazen-1-ium-1,2-diolate (MAHMA-
NONOate) and in the form of NaCN. Addition of 10-100 µM of NO-donor into a 50 µM 
solution of  8, 9, 10, and 11 in 50% v/v acetone/phosphate saline (PBS) buffer gave 
hypsochromic shift from 478 nm to 408 nm upon NO addition in the case of complex 7, 
decreased the signal at 500 nm upon NO addition in the case of complex 8, increased the 
signal at 470 nm upon CN- addition in the case of complex 9, and hypsochromic shift 
from 500 nm to 348 nm upon CN- addition in the case of complex 10.   The 1H-NMR 
and 19F-NMR spectra after reaction with CN- and NO showed characteristic resonances 
for non-coordinated triflate, THF, and CH3CN, suggesting that the organometallic 
product formed upon NO and CN- release both these ligands upon reaction with the 
respective substrate.   This project tries to explore the ability of rhenium complexes to 
bind to NO;1 and this change in the coordination sphere may produce an optical change 
that may be quantifiable.  
5.2. INTRODUCTION 
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Nitric oxide has several functions of particular importance for human health.2,3 It 
is now recognized as a key signaling molecule in the cardiovascular system and is also 
called endothelial derived relaxation factor (EDRF),4 as NO regulates blood pressure by 
relaxing blood capillaries, veins and arteries.  Several transition metal nitrosyl complexes 
have been reported,5 including some Re(I) complexes.6 Therefore, late transition metal 
chemistry should be explored for NO radical binding. 
The 1,4-Diazabutadienes (DAD or DAB) are ligands where intramolecular 
electron transfer can be studied.  These intramolecular electron transfers lead to valence 
tautomerization (VT).  1,4-diazabutadienes have two redox centers, which create the 
possibility of a bistable electronic state.7  Coordinating transition metals to non-innocent 
redox ligands may generate bistable electronic complexes, as shown in Scheme 5.1. 
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Scheme 5.1. Valence tautomerization (VT) produced by bistable electron state 
DAD. 
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Another possibility of “distortion” is “back-bonding” from the metal d-orbitals to 
the empty LUMO π* of the diamine ligand.8    There are complexes with osmium, 
ruthenium and rhodium;7 but rhenium chemistry with DAD has been barely explored. 
The synthesis of metal-DAD complexes can be summarized as substitution from 
metal halides or metal carbonyls with the DAD ligand, or by chelating ligand 
substitution, or by Schiff-base condensation.9  
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N
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Scheme 5.2 Summary of synthesis of metal-DAD complexes: a. from metal 
halide or carbonyl; b. from chelating ligand substitution; c. from Schiff-base 
condensation. 
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In prior work (Chapter 2- 4),  it was shown that (phen)Re(PPh3)(CO)2OSO2CF3, 
(phen)Re(THF)(CO)2OSO2CF3, and (phen)Re(CH3CN)(CO)2OSO2CF3 prepared in situ 
thermally or photochemically from (phen)Re(CO)3OSO2CF3, have the ability to react 
with NO under physiological conditions, producing a fluorescence response. These new 
DAD-Re-THF and DAD-Re-CH3CN analogs 8, 9, 10 and 11, which are introduced in 
this Chapter, show colorimetric responses to NO and CN- addition that can be ascribed to 
NO or CN- complexation by the Re center.  
5.3. EXPERIMENTAL PROCEDURES 
5.3.1. Materials and Methods 
All materials (purchased from Aldrich Chemical Co., ACROS organics, Cayman 
Chemicals, or Alfa Aesar) were standard reagent grade and were used without further 
purification, unless otherwise mentioned.  Toluene, used for the preparation of 3 and 5, 
was distilled and dried before use. PBS buffer (0.002 M in total phosphate, pH = 7.2,      
[NaCl] = 0.04 M) was prepared from K2HPO4, KH2PO4, and NaCl (all from Fisher 
Scientific). Water, used for preparation of the buffers and experiments with Nitric oxide, 
was filtered water (18 MΩ·cm-1) produced from a Millipore® nanopure diamond lab 
water system (Barnstead Thermolyne Corporation, Dubuque, IA). Deuterated solvents 
were purchased from Cambridge Isotope Laboratories Ltd. Photochemical reactions were 
carried out using a Rayonet photochemical reactor (Southern New England Ultraviolet, 
model RPR-100), equipped with a cooling fan and 10 phosphor coated low-pressure 
mercury lamps (λmax = 300 nm, light intensity = 5.2 ± 0.1 × 106 photon/sec/cm3). 
Fluorescence Spectra were recorded on a Jobin Yvon Horiba Fluoromax 3 
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spectrometer. 1H and 13C NMR spectra were recorded on a 400 Bruker NMR 
spectrometer and were referenced, using the residual solvent resonances. All chemical 
shifts, δ, are reported in ppm.  FT-IR spectra were recorded with a Perkin Elmer 
Spectrum 100 FT-IR Spectrometer. UV-Visible spectra were recorded with a Cary 100 
Spectrophotometer. 
5.3.2. Synthesis of (Xy-DAD)Re(CO)3Cl (4):   
100.0 mg of Re(CO)5Cl (276 µmol) and 73.0 mg of Xy-DAD (276 µmol)  were 
suspended in 25 mL of distilled anhydrous Toluene (final concentration of 11.0 mM), 
under N2 flow.  The suspension was refluxed for 2 hours.  The volatiles were evaporated 
to half volume. The solution changed from yellow to dark purple.   The bright purple 
powder product was filtered and was dried in vacuo at 40 oC.  117.3 mg, (70%). 1H-NMR 
(CDCl3): 2.29 (s, 6H), 2.59 (s, 6H), 7.20 (m, 6H, 3JH-H = 4.5 Hz), 8.75 (d, 2H, 3JH-H = 6.7 
Hz). 19F-{1H}-NMR (CDCl3): -78.3 ppm.  13C-NMR (CDCl3): 18.8 (s, 2C); 20.1 (s, 2C); 
128.1 (s, 2C); 128.3 (s, 2C); 128.8 (s, 2C); 129.6 (s, 2C); 150.3 (s, 1C); 166.6 (s, 1C).  
FT-IR (cm-1): 2021 (νCO, vs), 1931 (νCO, vs), 1885 (νCO, vs), 1637, 1499, 1468, 1382, 
1265, 1185, 1098, 1029, 771.    UV-Vis (in ethanol): λmax = 440 nm - br                          
(ε = 8075 mol-1cm-1).  Anal. Calc. for C21H20ClN2O3Re: C 44.24%, H 3.37%, N 4.91%.  
Found: C 43.96%, H 3.37%, N 4.89%. 
5.3.3. Synthesis of (Xy-DAD)Re(CO)3OSO2CF3 (5):   
50.0 mg of (Xy-DAD)Re(CO)3Cl (3) (87.7 µmol) and 20 mL of dichloromethane 
(4.3 µM of concentration) was placed in a 50 mL round bottom flask under N2 flow.   
0.15 mL of triflic acid was added dropwise.  The solution was stirred for 2 hours at room 
temperature.   The volatiles were evaporated to 1.0 mL.  The product was precipitated at 
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room temperature by adding 4.0 mL of diethyl ether.  The bright purple powder product 
was filtered and was dried in vacuo at 40 oC.  59.5 mg, (98%). 1H-NMR (CDCl3): 2.36 
(s, 6H), 2.39 (s, 6H), 7.23 (m, 6H, 3JH-H = 4.5 Hz), 8.77 (s, 2H). 19F-{1H}-NMR (CDCl3):      
-78.2 ppm. 13C-NMR (CDCl3): 18.6 (s, 2C); 18.9 (s, 2C); 128.1 (s, 2C); 128.7 (s, 2C); 
129.2 (s, 2C); 129.7 (s, 2C); 168.9.3 (s, 1C); 171.6 (s, 1C). FT-IR (cm-1): 2038 (νCO, vs), 
1951 (νCO, vs), 1909 (νCO, vs), 1313, 1233, 1204, 1190, 1005, 773, 624. Anal. Calc. for 
C21H20F3N2O6ReS: C 38.59%, H 3.09%, N 4.09%.  Found: C 38.25%, H 2.82%, N 
3.99%. 
5.3.4. Synthesis of (i-Pr-DAD)Re(CO)3Cl (6):   
100.0 mg of Re(CO)5Cl (276 µmol) and 105.0 mg of iPr-DAD (276 µmol)  were 
suspended in 25 mL of distilled, anhydrous Toluene (final concentration of 11.0 mM), 
under N2 flow.  The suspension was refluxed for 2 h.  The volatiles were evaporated to 
half volume. The solution changed from yellow to dark purple.   The bright purple 
powder product was filtered and was dried in vacuo at 40 oC.  123.0 mg, (55%). 1H-NMR 
(CDCl3): 1.16 (dd, 12H, 3JH-H = 14.5 Hz, 3JH-H = 6.8 Hz), 1.36 (d, 12H, 3JH-H = 6.8 Hz), 
2.80 (m, 2H, 3JH-H = 6.7 Hz), 3.92 (m, 2H, 3JH-H = 6.7 Hz), 7.72 (m, 6H, 3JH-H = 4.5 Hz), 
8.70 (s, 2H). 19F-{1H}-NMR (CDCl3): -78.3 ppm.  13C-NMR (CDCl3): 22.8 (s, 2C); 22.9 
(s, 2C); 26.2 (s, 2C); 26.8 (s, 2C); 28.0 (s, 2C); 28.2 (s, 2C); 123.8 (s, 2C); 124.9 (s, 2C); 
128.8 (s, 2C); 139.2 (s, 2C); 147.8 (s, 1C); 166.7 (s, 1C). FT-IR (cm-1): 2025 (νCO, vs), 
1934 (νCO, vs), 1916 (νCO, vs), 1501, 1464, 1441, 1362, 1355, 1321, 1170, 1102, 796, 
752, 638. Anal. Calc. for C21H20ClN2O3Re: C 51.05%, H 5.31%, N 4.10%.  Found:         
C 50.86%, H 5.15%, N 4.10%. 
5.3.5. Synthesis of (i-Pr-DAD)Re(CO)3OSO2CF3 (7):   
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50.0 mg of (i-Pr-DAD)Re(CO)3Cl (5) (87.7 µmol) and 20 mL of dichloromethane 
(4.3 mM of concentration) was placed in a 50 mL round bottom flask under N2 flow.   
0.15 mL of triflic acid was added dropwise.  The solution was stirred for 2 hours at room 
temperature.   The volatiles were evaporated to 1.0 mL.  The product was precipitated at 
room temperature by adding 4.0 mL of diethyl ether.  The bright purple powder product 
was filtered and was dried in vacuo at 40 oC.  59.5 mg, (98%). 1H-NMR (CDCl3): 1.15 
(dd, 12H, 3JH-H = 67.4 Hz, 3JH-H = 6.7 Hz), 1.38 (d, 12H, 3JH-H = 18.3 Hz, 3JH-H = 6.7 Hz), 
2.77 (m, 2H, 3JH-H = 6.7 Hz), 3.16 (m, 2H, 3JH-H = 6.7 Hz), 7.29 (m, 6H, 3JH-H = 3.5 Hz), 
7.37 (m, 6H, 3JH-H = 3.5 Hz), 8.75 (s, 2H).  19F-{1H}-NMR (CDCl3): -78.2 
ppm.          13C-NMR (CDCl3): 22.2 (s, 2C); 23.2 (s, 2C); 26.3 (s, 2C); 26.9 (s, 2C); 28.3 
(s, 2C); 28.4 (s, 2C); 124.3 (s, 2C); 124.9 (s, 2C); 129.4 (s, 2C); 139.2 (s, 2C); 141.0 (s, 
2C); 146.9 (s, 1C); 169.0 (s, 1C).  FT-IR (cm-1): 2038 (νCO, vs), 1953 (νCO, vs), 1922 
(νCO, vs), 1510, 1325, 1316, 1235, 1202, 1192, 1001, 796, 750, 633.   
5.3.6. Photochemical substitution reactions:  
All the solutions were irradiated with a Rayonet photochemical reactor (Southern 
New England Ultraviolet, model RPR-100), equipped with a cooling fan and 10 phosphor 
coated low-pressure mercury lamps (λmax = 300 nm, light intensity = 5.2 ± 0.1 × 106 
photon/sec/cm3).  After 75 minutes of irradiation, the colors of the solutions changed to 
darker colors.  Unfortunately, all of the organometallic complexes could not be isolated 
and it had to be prepared in situ.   
5.3.6.1. Synthesis of (Xy-DAD)Re(THF)(CO)2OSO2CF3 (8):  
 (Xy-DAD)Re(CO)3OSO2CF3 (4) (1 mg, 1.46µmol) 1.00 mL of anhydrous THF 
(final concentration 1.46 mM) were placed in a NMR tube. The solution was irradiated 
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for 75 minutes at room temperature.  This solution was used without further 
treatment. 1H-NMR (CDCl3): 2.24 (s, 6H), 2.36 (s, 6H), 7.10 (m, 6H, 3JH-H = 3.4 Hz), 
7.12 (m, 6H), 9.04 (s, 2H).   19F-{1H}-NMR (CDCl3): -78.1 ppm.  FT-IR (cm-1): 2036 
(νCO, vs), 1945 (νCO, vs), 1918 (νCO, vs), 1720 (νCO-O, vs), 1461, 1237, 1177, 1143, 
1091, 1030, 994, 921, 775, 638, 614.   
5.3.6.2. Synthesis of (Xy-DAD)Re(CH3CN)(CO)2OSO2CF3 (9):  
 (Xy-DAD)Re(CO)3OSO2CF3 (4) (1 mg, 1.46µmol) 1.00 mL of acetonitrile 
(final concentration 1.46 mM) were placed in a NMR tube. The solution was irradiated 
for 75 minutes at room temperature.  This solution was used without further 
treatment.  1H-NMR (CDCl3): 2.32 (s, 6H), 2.41 (s, 6H), 7.26 (m, 6H), 7.26 (m, 6H), 
8.86 (s, 2H).   19F-{1H}-NMR (CDCl3): -78.2 ppm.  FT-IR (cm-1): 2307 (νCN, w), 2040 
(νCO, vs), 1939 (νCO, vs-br), 1470, 1385, 1327, 1262, 1225, 1200, 1160, 1098, 1030, 775, 
701, 638. 
5.3.6.3. Synthesis of (i-Pr-DAD)Re(CH3CN)(CO)2OSO2CF3 (10):  
 (i-Pr-DAD)Re(CO)3OSO2CF3 (6) (1 mg, 1.26µmol) 1.00 mL of anhydrous 
tetrahydrofurane (final concentration 1.46 mM) were placed in a NMR tube. The solution 
was irradiated for 75 minutes at room temperature.  This solution was used without 
further treatment.  1H-NMR (CDCl3): 0.96 (dd, 12H, 3JH-H = 6.6 Hz,), 1.15 (dd, 12H, 3JH-
H = 6.5 Hz), 1.27 (dd, 12H, 3JH-H = 6.4 Hz), 1.28 (d, 12H, 3JH-H = 4.5 Hz), 1.33 (m, 
2H, 3JH-H = 5.4 Hz), 3.13 (m, 2H, 3JH-H = 6.6 Hz), 7.27 (m, 3H), 7.68 (m, 3H), 9.05 (s, 
2H).   19F-{1H}-NMR (CDCl3): -78.1 ppm.  FT-IR (cm-1): 2037 (νCO, vs), 1947 (νCO, vs), 
1922 (νCO, vs), 1722 (νCO-O, vs), 1460, 1335, 1238, 1174, 1143, 1091, 1032, 989, 919, 
802, 756, 637,614. 
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5.3.6.4. Synthesis of (i-Pr-DAD)Re(CH3CN)(CO)2OSO2CF3 (11):  
 (i-Pr-DAD)Re(CO)3OSO2CF3 (6) (1 mg, 1.26µmol) 1.00 mL of anhydrous 
tetrahydrofurane (final concentration 1.46 mM) were placed in a NMR tube.  The 
solution was irradiated for 75 minutes at room temperature. This solution was used 
without further treatment.  1H-NMR (CDCl3): 1.26 (dd, 12H, 3JH-H = 7.0 Hz, 3JH-H = 7.0 
Hz), 1.41 (d, 12H, 3JH-H = 9.8 Hz, 3JH-H = 6.9 Hz), 2.81 (m, 2H, 3JH-H = 6.8 Hz), 3.07 (m, 
2H, 3JH-H = 6.8 Hz), 7.45 (m, 4H), 7.48 (m, 2H), 8.99 (s, 2H).    19F-{1H}-NMR (CDCl3): 
-78.2 ppm FT-IR (cm-1): 2298 (νCN, w), 2041 (νCO, vs), 1942 (νCO, vs), 1722, 1633, 
1437, 1279, 1261, 1180, 1118, 1030, 749, 693, 637. 
5.3.7. Reactivity of α-diimine complexes with NO-donor:  
The amount of Re-DAD (stock solution in THF or CH3CN) complex solution 
needed for the final concentration was calculated assuming 4 mL of final 50 µM solution.  
Up to 2.0 mL of acetone was added in order to obtain a solution 50% v/v of total organic 
solvent.  Up to 2.0 mL of aqueous buffer was added in order to obtain 50% v/v aqueous 
solution total between Phosphate Buffer Saline pH=7.4; and 4 mM NO-donor stock 
solution was prepared in 0.04M NaOH; specific amounts were added to achieve a final 
NO-donor concentration going from 1 to 200 µM range. No more than 10 minutes 
elapsed from the dilution of the THF/CH3CN stock rhenium complex solution to the final 
addition of NO-donor. The solution was mixed thoroughly in a vortex and sonicated for 
90 minutes at room temperature.  At higher concentrations of NO-donor,  the solutions 
became clear. The UV-Visible spectra of this set of solutions were recorded from 300 nm 
to 650 nm. 
5.3.8. Reactivity of α-diimine complexes with NaCN: 
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The amount of Re-DAD (stock solution in THF or CH3CN) complex solution 
needed for the final concentration was calculated assuming 4 mL of final 50 µM solution.  
Up to 2.0 mL of acetone was added in order to obtain a solution 50% v/v of total organic 
solvent.  Up to 2.0 mL of aqueous buffer was added in order to obtain 50% v/v aqueous 
solution total between Phosphate Buffer Saline pH=7.4; and 4 mM NaCN stock solution 
was prepared in DI water; specific amounts were added to achieve a final NaCN 
concentration going from 1 to 100 µM range. No more than 10 minutes elapsed from the 
dilution of the THF/CH3CN stock rhenium complex solution to the final addition of NO-
donor. The solution was mixed thoroughly in a vortex and sonicated for 90 minutes at 
room temperature.  At higher concentrations of NO-donor, the solutions became yellow. 
The UV-Visible spectra of this set of solutions were recorded from 300 nm to 650 nm. 
5.3.9. Comparison studies with other ions: 
The solutions of 4 mM NaNO2, NaNO3, NaClO4, NaOCl, H2O2, and NaCN were 
prepared in ultrapure water.   1O2 was prepared in situ, mixing same the amounts of 
NaOCl and H2O2.  Stock solutions of (Xy-DAD) rhenium complexes were diluted in 
acetone for preparing 200 µM solutions.  2.8 mL of 0.002M PBS pH 7.2 was added to 1 
mL of the previous prepared Re solutions.  100 µL of PBS was added to the first tube, 
this tube will be the standard (std).  To the rest there were added 100 µL of each of the 
competitive ions and/or species (NO2-, NO3-, ClO4-, ClO-, H2O2, CN-, and 1O2).  After 
the solutions were allowed to react for 15 min,   a UV-Visible spectrum was measured.  
100 µL of NO-donor were added to each tube and all the solutions were allowed to react 
for 1 h, a second UV spectrum was recorded. 
5.4. RESULTS 
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5.4.1. Synthesis of (R-DAD)Re(L)(CO)2OSO2CF3 (R = Me or i-Pr; L = THF or 
CH3CN) 
Complexes 8, 9, 10, and 11 were synthesized in situ by photochemical 
substitution of CO from (R-DAD)Re(CO)3SO3CF3. The products were characterized 
by 1H and 13C-NMR and FT-IR. 
N
N
RR
RR
Re
CO
CO
CO
Cl
N
N
RR
RR
Re
CO
CO
CO
OTf
NN
R
R
R
R
Re
COOC
THFTfO
NN
R
R
R
R
Re
COOC
MeCNTfO
Re(CO)5Cl
DAD
Toluene
HOTf
DCM
THF
hν
MeCN
hν
 
Scheme 5.3 Synthetic path for DAD-rhenium complexes 
5.4.2. Reactivity of α-diimine complexes with NO-donor: 
In the case of Figure 5.1, which shows the spectrum UV – Visible of the 
interaction of (Xy-DAD)Re(THF)(CO)2OSO2CF3 (8) with NO-donor, in the form of 
MAHMA NONOate from 0 – 200 µM.  It can be seen that the signal decreases at 478 nm 
and shifts hypsochromically, meanwhile the absorbance at 408 nm increases with an 
isosbestic point around 451 nm.  This color change can be observed by the naked eye. 
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Figure 5.1 Interaction of (Xy-DAD)Re(CO)2(THF)OSO2CF3 with NO-donor, 
acetone/PBS (1:1)  
Complex 8 prepared photochemically on a 1 mg scale (1.67 mM in THF) showed 
also significant colorimetric response to NO addition both at 478 nm (decrease) and at 
408 nm (increase). The UV-Vis spectrum of 8 in THF/acetone/buffer 2/48/50 shows one 
absoption signal at 478 nm. Figure 5.2 shows the plot of the local maxima and minima 
on the UV-Visible spectrum of 8 upon NO gradual addition, in the form of NO-donor 
MAHMA-NONOate (0-200 µM) dissolved in 0.04 M NaOH.  The graph also shows the 
ratio of the absorbance at 408 nm vs the absorbance at 478 nm.  This plot shows a linear 
dependency at lower NO-donor concentrations. 
[NO donor] 
0 – 150 µM 
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Figure 5.2 Relationship and ratio of the reaction of (Xy-DAD)Re(CO)2(THF)OSO2CF3 
with NO-donor, acetone/PBS (1:1) 
 
In the case of Figure 5.3, which shows the spectrum UV – Visible spectrum of 8 
in acetonitrile/acetone/buffer 2/48/50 of the interaction of (Xy-
DAD)Re(CH3CN)(CO)2OSO2CF3 (9) with NO-donor, in the form of MAHMA 
NONOate in 0.04 M NaOH, from 0 – 200 µM .  It can be seen that the signal decreases at 
496 nm and shifts hypsochromically.  In the case of figure 5.3 Interaction of 9 with NO-
donor, it is shown that the signal at 496 nm decreases consistently when the NO-donor 
concentration increases.  Like the previous case, this color change can be observed by the 
naked eye.  
 
[NO donor] (mM) 
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Figure 5.3 Interaction of (Xy-DAD)Re(CO)2(CH3CN)OSO2CF3 with NO-donor, 
Acetone/PBS (1:1) 
 
The results of the interaction of NO-donor with (i-Pr-
DAD)Re(CO)2(CH3CN)OSO2CF3 and (i-Pr-DAD)Re(CO)2(THF)OSO2CF3 were not 
clear because of the lower solubility of those complexes in mixed aqueous media.  Even 
though the tendency was still observed, there was precipitation, which produced 
scattering and gave erratic absorbances. 
5.4.3. Reactivity of α-diimine complexes with NaCN: 
In the case of Figure 5.4, which shows the spectrum UV – Visible spectrum of 8 
in THF/acetone/buffer 2/48/50 of the interaction of (Xy-DAD)Re(THF)(CO)2OSO2CF3 
(9) with NaCN, from 0 – 100 µM .  It can be seen that the signal decreases at 480 nm and 
shifts hypsochromically.  In the case of figure 5.4 Interaction of 8 with NaCN, it is shown 
that the signal at 480 nm increases consistently when the NO-donor concentration 
increases.  Like the previous case, this color change can be observed by the naked eye.  
There is a little decrease of the signal at 344 nm. 
 
 
[NO donor] 
0 – 150 µM 
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Figure 5.4 Interaction of (Xy-DAD)Re(CO)2(THF)OSO2CF3 with NaCN, 
acetone/PBS (1:1) 
 
In the case of Figure 5.5, which shows the spectrum UV – Visible of the 
interaction of (Xy-DAD)Re(CH3CN)(CO)2OSO2CF3 (9) with NaCN from 0 – 100 µM.  
It can be seen that the signal decreases at 500 nm and shifts hypsochromically, 
meanwhile the absorbance at 348 nm increases with an isosbestic point around 361 nm.  
This color change can be observed by the naked eye. 
 
[CN-] 
0 – 150 µM 
115 
 
 
Figure 5.5 Interaction of (Xy-DAD)Re(CO)2(CH3CN)OSO2CF3 with NaCN, 
acetone/PBS (1:1) 
 
The graph also shows the ratio of the absorbance at 500 nm vs the absorbance at 
348 nm.  This plot shows a linear dependency at lower NO-donor concentrations.  
Figure 5.6 shows the plot of the local maxima and minima on the UV-Visible spectrum 
of 9 upon CN- gradual addition, in the form of NaCN (0-100µM).  The graph also shows 
the ratio of the absorbance at 348 nm vs the absorbance at 500 nm.  This plot shows a 
linear dependency at lower NO-donor concentrations. 
 
 
 
[CN-] 
0 – 100 µM 
116 
 
 
Figure 5.6 Relationship and ratio of the reaction of (Xy-
DAD)Re(CO)2(CH3CN)OSO2CF3 with NaCN, acetone/PBS (1:1) 
 
The results for the interaction of NaCN with (i-Pr-
DAD)Re(CO)2(CH3CN)OSO2CF3 and (i-Pr-DAD)Re(CO)2(THF)OSO2CF3 were not 
clear because of the lower solubility of those complexes in mixed aqueous media.  Even 
though the tendency was still observed, there was precipitation, which produced 
scattering and gave erratic absorbances. 
5.4.4. Comparison studies with other ions: 
A study was conducted in order to investigate the behavior of these dyes in the 
presence of competitive anions and/or oxidant species.  Re(I) centers and DAD ligands 
are known by their redox properties.  The selected anions and oxidant species were NO3-, 
NO2-,ClO4-, ClO-, H2O2, CN- and 1O2 (this one was prepared in situ by reacting H2O2 
with ClO-).  Also, it was investigated whether the dyes still have activity towards NO 
after the reaction with these species. 
[CN-] (mM) 
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Figure 5.7 shows the UV – Vis maxima of (Xy-DAD)Re(THF)(CO)2OSO2CF3 
(8) at 408 nm, in the presence of strong oxidants the color (qualitative) and the 
absorbance at 500 nm (quantitative) decreases to almost zero.  In the presence of weak 
oxidants the color was diluted, in the presence of CN- the solution turned yellow and the 
spectrum change considerably with a maximum of 348 nm. 
 
Figure 5.7 Comparison Studies among (Xy-DAD)Re(THF)(CO)2OSO2CF3 with NO-
donor and Different Ions at 500 nm 
 
Figure 5.8 shows the UV – Vis maxima of (Xy-
DAD)Re(CH3CN)(CO)2OSO2CF3 (9) at 500 nm, in the presence of strong oxidants the 
color (qualitative) and the absorbance at 500 nm (quantitative) decreases to almost zero.  
In the presence of weak oxidants the color was diluted, in the presence of CN- the 
solution turned yellow and the spectrum change considerably with a maximum of 348 
nm.  In the case of CN-, there is not difference between the 8 and 9 spectra.  There is 
possibly substitution of THF or CH3CN for CN-. 
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Figure 5.8 Comparison studies among (Xy-DAD)Re(CH3CN)(CO)2OSO2CF3 with      
NO-donor and Different Ions at 500 nm 
 
The results obtained by (Xy-DAD)Re(CH3CN)(CO)2OSO2CF3 and                             
(Xy-DAD)Re(THF)(CO)2OSO2CF3 in the presence of competitive ions can be 
summarized as follows:  a) in the presence of NO2-, for both dyes, there were minor 
changes, and activity toward NO was not affected; b) in the presence of weak oxidants 
NO3- and ClO4-, the results were not conclusive; activity toward NO was partially lost 
because of the partial oxidation of Re(I) center; c) in the case of CN-, there was ligand 
substitution, and the reaction exhibited a change of color from red to yellow - CN- and 
NO are iso-electronics/iso-energetic and they compete for the same soft metal center; d) 
in the case of the strong oxidants ClO-, H2O2, and 1O2, the color was lost completely, in 
addition to the activity toward NO, d6 Re(I) possesses a 3MLCT transition, which is 
responsible for generating the optical response (as describe in section 1.4.3.) toward NO.  
Oxidation, partial or total, of the metal center from Re(I) to Re(III) deactivates the 
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organometallic dye because d4 Re(III) does not possess 3MLCT transition, which is 
required for the optical response. 
5.5. CONCLUSIONS 
Organometallic d6 Re(I) complexes, with the DAD ligands, which can be used as 
NO and cyanide sensors.  Re-DAD complexes are less soluble in mixed aqueous media 
than the phenanthroline analogs; they need twice the amount of acetone in the solvent 
mixture.  Xy-DAD complexes are more soluble than     i-Pr-DAD ones.   In the presence 
of oxidants, the Re complexes are deactivated by oxidation presumably because non-d6 
Re centers do not possess the 3MLCT transition state needed for the optical response. 
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6. CONCLUSION 
As conclusion of this study, (LN2)Re(L)(CO)2OTf complexes (LN2 = phen or 
DAD;  L = THF, CH3CN, and PPh3) can be used as NO fluorescence sensors.   The 
response is significantly stronger when the reaction with NO-donor is performed under 
anaerobic conditions indicating that NO is the real substrate instead of NO oxidation 
products.  Controlling the NaCl concentration in the buffer allows converting these dyes 
into ratiometric response dyes.  The spectroscopy data elucidate a mechanism involving 
the detachment of two labile ligands. The complex (phen)Re(PPh3)(CO)2OTf (1) has the 
most value as NO sensing fluorescent dye, because of it has the highest quantum yield of 
the Re-family group, and it is easy to manipulate because of it is isolable and it can be 
stored in powder form.  This project can be extended in the future to other fluorescent 
ligands and Re complexes with higher quantum yields that can sense NO under 
physiological conditions. 
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APPENDIX 1. STUDY OF THE FLUORESCENT ORGANOMETALLIC 
COMPLEX (dppz)Re(L)(CO)2OSO2CF3  AS A NO SENSOR (L=THF, CH3CN, 
and PPh3). 
A1.1. ABSTRACT 
Dipyrido[3,2-a:2',3'-c]phenazine (dppz) is used as fluorophore for DNA 
intercalator and fluorescent dye.  (dppz)Re(THF)(CO)2OSO2CF3 (A2), 
(dppz)Re(PPh3)(CO)2OSO2CF3 (A3), and (dppz)Re(PPh3)(CO)2OSO2CF3 (A4), which 
can be obtained photochemically from (dppz)Re(CO)3OSO2CF3 (A1) shows 
fluorescence quenching response upon NO addition, which was added in the form of NO-
donor Z-1-N-mthyl-N-[6-(N-methylammoniohexyl)amino]diazen-1-ium-1,2-diolate 
(MAHMA-NONOate). Addition of 10-150 µM of NO-donor into a 25 µM solution of 
(dppz)Re(CH3CN)(CO)2OSO2CF3 or (dppz)Re(CH3CN)(CO)2OSO2CF3 in 25% v/v 
acetone/phosphate saline (PBS) buffer gave fluorescence quenching at 458 nm and 
586nm, upon excitation at 360 nm and 380 nm. The 1H-NMR and 19F-NMR spectra after 
reaction with NO showed characteristic resonances for non-coordinated triflate and the L 
ligand (L = THF, PPh3 or CH3CN), suggesting that the organometallic product formed 
upon NO releases both these ligands upon reaction with NO.   This study expands our 
newly demonstrated approach for the design of fluorescent NO sensors based on NO 
coordination to Re;1 A1 is an isolable complex, which is stable at room temperature and 
therefore can be used as starting material for NO sensing organometallic dyes. 
A1.2. INTRODUCTION 
Fluorescent materials are attracting considerable interest due to their potential 
sensory, biochemical, medical, and photoelectronic applications, in addition to other 
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possible uses.2 One type of fluorescent material that have been attracting attention are 
Dipyrido[3,2-a:2',3'-c]phenazine Ru(II) complexes. They have been used as “light 
switches” when they bind DNA.3 Through NMR, it was proved that Ru(phen)2(dppz)+2 
intercalated double stranded DNA employing the dppz moiety.  Ru(dppz) complexes 
were also used as electrochemical indicators for DNA double-helix’s detection.4  
In many metal polypyridyl complexes, the most important state is the metal-to-
ligand charge-transfer (MLCT) state, which is important to defining photophysical 
properties.5 The Barton et al. study proved that dppz become emissive when the nitrogens 
are shielded from water; otherwise, these complexes are non-emissive.6     
Many photophysical and theoretical studies have suggested that Re(I)−and 
Ru(II)−dppz complexes exhibit two low-energy triplet metal to ligand charge-transfer 
(MLCT) states and one triplet ligand-centered state.7 The 3MLCT (phen) state is emissive 
because of environment stabilization, while the 3MLCT (phz) state is a dark state.8  
dppz complexes are weakly emissive in CH2Cl2.  For most complexes, their 
emission is short, decaying in less than 10 ns after the laser pulse.9 It was found that  
[Re(CO)3(dppz)Cl] complexes possess MLCT states based on the phen portion of the 
dppz ligands, which does not occur in [Re(CO)3(dppz)(py)]PF6, which is L+1, in which 
the phenazine is responsible of the transition. Many of the molecular orbitals in these 
compounds show extensive delocalization across the dppz ligand, in particular for these 
cationic species, which have L+1 extended over the whole dppz system (Figure A1.1) 
destabilizing the orbital.  
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Figure A1.1 Energy diagram for (a) [(dppz)Re(CO)3(py)]PF6 and (b) (dppz)Re(CO)3Cl  
A1.3. EXPERIMENTAL SECTION 
A1.3.1. Materials and Methods 
(dppz)Re(CO)3Cl10 was prepared with a modification of the previously reported 
procedure for (phen)Re(CO)3Cl.11 All other materials (purchased from Aldrich Chemical 
Co., ACROS organics, Cayman Chemicals, or Alfa Aesar) were standard reagent grade 
and were used without further purification, unless otherwise noted.  PBS buffer (0.002 M 
in total phosphate, pH = 7.2, [NaCl] = 0.04 M) was prepared from K2HPO4, KH2PO4, 
and NaCl (all from Fisher Scientific). Filtered water (18 MΩ·cm-1) produced from a 
Millipore® nanopure diamond lab water system (Barnstead Thermolyne Corporation, 
Dubuque, IA) was used for preparation of the buffers and experiments with NO. 
Deuterated solvents were purchased from Cambridge Isotope Laboratories Ltd. 1H 
and 13C NMR spectra were recorded on a 400 Bruker NMR spectrometer and were 
referenced, using the residual solvent resonances. All chemical shifts, δ, are reported in 
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ppm.  FT-IR spectra were recorded with a Perkin Elmer Spectrum 100 FT-IR 
Spectrometer.   
A1.3.2. Synthesis of (dppz)Re(CO)3OSO2CF3:  
The complex (dppz)Re(CO)3OSO2CF3 was prepared by a modification of the 
previously reported procedure for (phen)Re(CO)3OSO2CF3.12  150.0 mg of 
(dppz)Re(CO)3Cl (255µmol) and 10 mL of dichloromethane (final concentration: 25.5 
mM) were placed in a 50 mL round bottom flask under N2 flow.    250 µL of HOSO2CF3 
were added dropwise in a 30 minute period, after the solution was left stirring for 2 h.  
The color changed during reflux from orange to red. 250 µL of ethanol were added and 
the volatiles were evaporated to 1.0 mL. The product was precipitated at room 
temperature by adding 4.0 mL of diethyl ether.  The bright orange powder product was 
filtered and was dried in vacuo at 40 oC.  168.1 mg, (93%). 1H-NMR (CDCl3): 8.09 (dd, 
2H, 3JH-H = 6.6 Hz, 3JH-H = 3.4 Hz), 8.10 (dd, 2H, 3JH-H = 8.2 Hz, 3JH-H = 5.2 Hz), 8.48 
(dd, 2H, 3JH-H = 6.6 Hz, 3JH-H = 3.4 Hz), 9.50 (dd, 2H, 3JH-H = 5.2 Hz, 3JH-H = 1.4 Hz), 
9.96 (dd, 2H, 3JH-H = 8.2 Hz, 3JH-H = 1.4 Hz).   19F-{1H}-NMR (CDCl3): -78.1 ppm.  FT-
IR (cm-1): 2015 (νCO, s), 1875 (νCO, s), 1629, 1604, 1584, 1520, 1427, 1417, 1350, 1321, 
1277, 1255, 1223, 1145, 1109, 1058, 1030, 908, 848, 808, 780, 723, 638. UV-Vis (in 
ethanol): λmax = 360 nm - br (ε = 1840 mol-1cm-1), 380 nm - (ε = 1840 mol-1cm-1). 
A1.3.3. Photochemical substitution:  
All the solutions were irradiated with a Rayonet photochemical reactor (Southern 
New England Ultraviolet, model RPR-100), equipped with a cooling fan and 10 phosphor 
coated low-pressure mercury lamps (λmax = 300 nm, light intensity = 5.2 ± 0.1 × 106 
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photon/sec/cm3).  After 75 min. of irradiation, the colors of the solutions changed to 
darker colors.   
A1.3.3.1. Synthesis of (dppz)Re(THF)(CO)2OSO2CF3 (A2):  
 (dppz)Re(CO)3OSO2CF3 (A1) (1 mg, 1.46 µmol) 1.00 mL of anhydrous THF 
(final concentration 1.46 mM) were placed in a NMR tube. The solution was irradiated 
for 75 min. at room temperature.  This solution was used without further treatment. 1H-
NMR (CDCl3): 7.98 (dd, 2H, 3JH-H = 6.6 Hz, 3JH-H = 2.8 Hz), 8.12 (dd, 2H, 3JH-H = 8.2 
Hz, 3JH-H = 5.2 Hz), 8.48 (dd, 2H, 3JH-H = 6.6 Hz, 3JH-H = 3.4 Hz), 9.44 (dd, 2H, 3JH-H = 
5.2 Hz, 3JH-H = 1.4 Hz), 9.87 (dd, 2H, 3JH-H = 8.2 Hz, 3JH-H = 1.4 Hz).  19F-{1H}-NMR 
(CDCl3): -78.4 ppm.  FT-IR (cm-1): 2032 (νCO, s), 1915 (νCO, s), 1640, 1460, 1442, 1423, 
1344, 1320, 1282, 1241, 1177, 1115, 1064, 1030, 908, 848, 808, 780, 723, 638.   
A1.3.3.2. Synthesis of (dppz)Re(CH3CN)(CO)2OSO2CF3 (A3):  
 (dppz)Re(CO)3OSO2CF3 (A1) (1 mg, 1.46µmol) 1.00 mL of acetonitrile (final 
concentration 1.46 mM) were placed in a NMR tube. The solution was irradiated for 75 
minutes at room temperature.  This solution was used without further treatment.  1H-
NMR (CDCl3): 2.24 (s, 3H), 8.04 (d, 2H, 3JH-H = 6.6 Hz, 3JH-H = 3.4 Hz), 8.13 (dd, 
2H, 3JH-H = 8.2 Hz, 3JH-H = 5.2 Hz), 8.46 (dd, 2H, 3JH-H = 6.6 Hz, 3JH-H = 3.4 Hz), 9.38 (d, 
2H, 3JH-H = 4.4 Hz), 10.01 (dd, 2H, 3JH-H = 7.3 Hz). 19F-{1H}-NMR (CDCl3): -78.3 ppm.  
FT-IR (cm-1): 2322 (νCN, w), 2042 (νCO, vs), 1953 (νCO, vs), 1941 (νCO, vs), 1924 (νCO, 
vs), 1642, 1496, 1422, 1358, 1283, 1252, 1226, 1163, 1031, 820, 775, 731, 639. 
A1.3.3.3. Synthesis of (dppz)Re(PPh3)(CO)2OSO2CF3 (A4):  
 (dppz)Re(CO)3OSO2CF3 (A1) (1 mg, 1.46µmol) 1.00 mL of acetonitrile (final 
concentration 1.46 mM) were placed in a NMR tube. The solution was irradiated for 75 
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minutes at room temperature.  This solution was used without further treatment.  1H-
NMR (CDCl3): ): 6.96 (t, 3H, 3JH-H = 7.0 Hz), 7.39 (dd, 6H, 3JH-H = 7.6 Hz, 3JH-H = 2.0 Hz), 7.62 
(dd, 6H, 3JH-H = 12.5 Hz, 3JH-H = 7.2 Hz), 8.06 (d, 2H, 3JH-H = 6.6 Hz, 3JH-H = 3.4 Hz), 8.09 
(dd, 2H, 3JH-H = 8.3 Hz, 3JH-H = 5.2 Hz), 8.49 (dd, 2H, 3JH-H = 6.6 Hz, 3JH-H = 3.4 Hz), 
9.56 (dd, 2H, 3JH-H = 5.2 Hz, 3JH-H = 1.8 Hz), 9.93 (dd, 2H, 3JH-H = 8.3 Hz, 3JH-H = 1.8 
Hz).   19F-{1H}-NMR (CDCl3): -78.4 ppm FT-IR (cm-1): 2032 (νCO, s), 1932 (νCO, s), 
1914 (νCO, s), 1648, 1460, 1439, 1366, 1260, 1178, 1120, 1052 (s-br), 897, 803, 780, 
723, 696. 
A1.3.4. Fluorescence experiments with NO-donor  
In a typical experiment, a 100 µM solution of (dppz)Re(THF)(CO)2OSO2CF3 
complex was prepared from 1.67 mM stock solution of (dppz)Re(THF)(CO)2OSO2CF3  
in THF and acetone was added up to 1.000 mL of total solution of Re complex.  2.75 mL 
to 3.00 mL of aqueous PBS buffer (pH = 7.2) was added. Then 0 to 250 µL of 4 mM 
stock solution of MAHMA-NONOate NO-donor, in 0.04 M NaOH, were added in order 
to obtain 75% v/v aqueous/organic solution and a final NO-donor concentration from 0 to 
200 µM range, while the concentration of Re complex remained constant at 25 µM. No 
more than 10 minutes elapsed from preparation of the organic phase to the addition of the 
NO-donor. The solution was mixed thoroughly in a vortex and sonicated for 90 minutes 
at room temperature.  The fluorescence of all solutions was measured with a λexc = 360 
nm and 380 nm.  The emission spectrum was recorded from 400 nm to 700 nm.   
A1.3.5. UV-Visible spectroscopy experiments with NO-donor  
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The (dppz)Re(THF)(CO)2OSO2CF3 (A2), (dppz)Re(THF)(CO)2OSO2CF3 (A3), 
and (dppz)Re(THF)(CO)2OSO2CF3 (A4) samples were prepared in the same way that in 
A1.3.4. The UV-Visible spectra of all solutions were recorded from 300 nm to 600 nm.   
A1.3.6. 1H-NMR and 19F-NMR Studies of dppz complexes 
The performed procedure was similar to sections 2.3.5 and 3.3.4; the stock 
solutions of A2, A3 and A4 after reaction with NO-donor were extracted with 
dichloromethane.  The organic fractions were dried with Na2SO4 and the volatiles were 
evaporated.  The residue was redissolved with chloroform-d and NMR was performed.   
A1.4. RESULTS AND DISCUSSION 
A1.4.1. Synthesis of (dppz)Re(L)(CO)2OSO2CF3  
Complexes A2, A3 and A4 were synthesized by photochemical substitution of CO 
from (dppz)Re(CO)3SO3CF3 (A1).  The products were characterized by 1H and FT-IR. 
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Scheme A1.1 Synthesis of (dppz)Re(L)(CO)2OSO2CF3  
 
A1.4.2. Fluorescence studies with addition of NO-donor  
The PPh3 and CH3CN complexes A2 and A3 show no fluorescence spectra. The 
Re-(dppz)(CO)2(THF)OTf complex A2 showed small fluorescence response to NO 
addition; UV-Vis spectrum exhibited two signals at 360 nm and at 380 nm. Figure A1.1 
shows the fluorescence spectrum of A2 at λexc = 360 nm, upon NO gradual addition, in 
the form of NO-donor MAHMA-NONOate (0 - 150µM) dissolved in 0.04 M NaOH. The 
emissions at 570 nm and 424 nm decrease slightly upon NO addition and the intensity 
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changes show linearity with NO-donor concentration (Figure A1.2). 
 
Figure A1.2 Fluorescence Response upon NO-donor addition (0-150 µM) to 25 µM 
of Re complex A1 in acetone/PBS aqueous buffer 25/75 v/v, (λexc = 360 nm) 
 
Figure A1.3 shows the fluorescence spectrum of A2 at λexc = 380 nm upon NO 
gradual addition, in the form of NO-donor MAHMA-NONOate (0-150µM) dissolved in 
0.04 M NaOH.   The emission responses were similar to those observed for λexc = 360 
nm.   
[NO donor] 
0 – 150 µM 
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Figure A1.3 Fluorescence Response upon NO-donor addition (0-150 µM) to 25 µM 
of Re complex A1 in acetone/PBS aqueous buffer 25/75 v/v, (λexc = 380 nm) 
 
A1.4.3. UV-Visible spectroscopy studies with addition of NO-donor  
The THF, PPh3 and CH3CN complexes (A2, A3 and A4, respectively) showed 
significant response upon NO addition under physiological conditions in UV-Vis spectra.  
Figure A1.4 shows the effects upon NO addition, in the form of NO-donor MAHMA-
NONOate (0 – 150 µM) dissolved in 0.04 M NaOH to the CH3CN complex A4. The 
absorption at 305 nm, 360 nm, 380 nm increased steadily upon NO addition and its 
intensity showed linear dependence with NO-donor concentration.  
[NO donor] 
0 – 150 µM 
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Figure A1.4. UV-Vis Spectra of A4 (25 µM) after addition of different amounts of NO 
donor, in acetone/buffer 25:75.   
 
Figure A1.5 shows the UV-Vis response of A4 with NO concentration.  At low 
concentrations the change is not noticeable. After addition of 100 µM NO, the change in 
response became more noticeable. 
 
 Figure A1.5 UV-Visible absorbance of A4 25 µM 6 vs NO concentration, in 
acetone/buffer 25:75,    
[NO donor] 
0 – 150 µM 
 
[NO donor] (mM) 
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Figures A1.5 and A1.6 show the UV-Vis spectral responses upon NO addition to 
THF and PPh3 dppz complexes A2 and A3.   After 75 µmol NO addition, there is a 
change in the slope of the linear response. 
 
Figure A1.6 UV-Visible absorbance of A2 25 µM 6 vs NO concentration, in 
acetone/buffer 25:75  
 
Figure A1.7 UV-Visible absorbance of A3 25 µM 6 vs NO concentration, in 
acetone/buffer 25:75 
 
[NO donor] (mM) 
[NO donor] (mM) 
134 
 
A1.4.4. 1H-NMR and 19F-NMR studies on dppz complexes 
Similar to the phenanthroline analogs, 1H-NMR showed, for all three NO-active 
dppz complexes (dppz)Re(L)(CO)2OTf (THF for A2, PPh3 for A3, and CH3CN A4), that  
after reaction with NO-donor, the chemical shift of “free – unbound” L – ligand plus a 
generic “dppz-Re” signals, which are similar for the three dppz-Re complexes.  19F-NMR 
showed that after reaction with NO-donor there is not CF3SO3- signal (or other                  
F – containing species).   These results help to prove that triflate group (CF3SO3-) gets 
detached from the metal center, and it was discarded in the aqueous layer. 
All dppz complexes exhibited only small, yet linear changes in response upon NO 
addition.  Both the initial fluorescence intensities, and the responses of dppz complexes 
upon NO addition were noteably lower than for the phen complexes. Partial protonation 
of the basic N on the dppz framework can explain the lower initial fluorescence 
intensities in all complexes, because of the dppz 3MLCT is dark; opposite to 3MLCT of 
phen with is emissive due to environment stabilization. The lower response to NO 
addition is due to dppz complexes are slightly inert and Re-dppz are less prone to ligand 
substitution. 
A1.5. CONCLUSION 
 The (dppz)Re(L)(CO)2OSO2CF3 complexes have been synthesized and 
characterized.  These complexes react with NO under physiological conditions, 
producing a UV-Vis response. The THF complex A2 showed also small quenching in 
fluorescence, with linear response to NO addition. NMR Studies of all three NO-active 
complexes proved that after reation with NO triflate and L ligand get disassociated from 
the metal center.  The similarities between phen, DAD, and dppz complexes, toward 
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reaction with NO, help to elucidate the possible mechanisms that undergo these Re(I) 
complexes. 
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APPENDIX 2.  ESI-MS STUDY OF REACTIVITY OF Re-PHENANTHROLINE 
COMPLEXES WITH NO 
A2.1. ABSTRACT 
The ESI-MS spectra of the phenanthroline complexes Re(phen)(CO)3LX 
(L=PPh3, CO, THF, X=Cl-, OTf-) were collected, after reaction with NO donor. Spectra 
of Re(phen)(CO)2PPh3OTf (1) and Re(phen)(CO)2(THF)OTf (2) after reaction with NO 
showed presence of a peak at m/z = 339.4 (for 1) and m/z = 391.2 (for 2) corresponding 
to [Re(CO)2(NO)2(H2O)2]+ (for 1) and [Re(CO)2(NO)(acetone)2]+ (for 2). The ESI-MS 
spectra of control reactions of Re(phen)(CO)3Cl and Re(phen)(CO)3OTf with NO, show 
no peaks of any NO-metal containing species, as expected, since these species do not 
react with NO (See Chapter 2). Instead those spectra showed a peak at m/z = 492.2, 
which corresponds to the species [Re(phen)(CO)(H2O)2(acetone)]+.  This peak was also 
observed along with other decomposition products for the spectra of 1 and 2 after NO 
reaction, yet in lower intensity than the peaks of the NO-containing products. 
A2.2. INTRODUCTION 
Due to its versatility, electrospray ionization mass spectrometry (ESI-MS) offers 
the development for identification of several organic and inorganic compounds.1  ESI-MS 
can detect and characterize single species in complex matrixes, which are not involved in 
equilibria or solvatation processes.   This is very important for the characterization of 
metal-ligand systems.  ESI-MS may indicate the stoichiometry of new complexes. 2,3,4 
The ESI-MS technique uses soft ionization, this characteristic decreases excessive 
fragmentation and parent compounds in solution can be detected with this technique.  
Charge and nature of the analyte is determinant for choosing the mode in which can be 
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detected more efficiently.  This technique offers two modes positive and negative, giving 
different patterns from the same molecule.5a Important structural information can be 
recovered directly from the m/z; in the case of structural conflicts, MS-MS spectra or 
isotopic pattern can be used for full identification.5b ESI-MS has been used to 
characterize cationic Re(I)-phenanthroline complexes.6   
A2.3. SAMPLE PREPARATION 
 (phen)Re(PPh3)(CO)2OSO2CF3 (1), (phen)Re(THF)(CO)2OSO2CF3 (2), 
(phen)Re(CO)3Cl, or (phen)Re(CO)3OSO2CF3 (1 mg of each one) were added to 0.05 
mL of THF in four separate 10 mL vials.  1.6 mL of acetone was added.   Then 2.4 mL of 
PBS aqueous buffer (pH = 7.2) and 0.2 mL of stock NO-donor solution 5 mM in 0.04 M 
NaOH were added sequentially.  The mixtures were vortexed for 30 sec and then 
sonicated for 3h at room temperature. Dichloromethane was added (3 x 10 mL), and the 
organic layer was dried with anhydrous sodium sulfate.  In order to remove uncomplexed 
phenanthroline products, the organic phases were washed with 1 M hydrochloric acid, 
followed by 1 M sodium bicarbonate, rinsed with deionized water, and dried with 
anhydrous sodium sulfate.  The volatiles were evaporated; the solid residues were 
redissolved in acetonitrile.  The samples were measured using ESI in positive mode. 
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Figure A2.1 ESI-MS positive mode spectrum of (phen)Re(CO)2(THF)OTf 
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Figure A2.2 ESI-MS positive mode spectrum of (phen)Re(CO)2(PPh3)OTf 
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Figure A2.3 ESI-MS positive mode spectrum of (phen)Re(CO)3Cl 
E:\11148 09/05/2012 04:46:07 PM 2
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Figure A2.4 ESI-MS positive mode spectrum of (phen)Re(CO)3OTf 
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A2.4. RESULTS AND DISCUSSION 
Different structures can be assigned according to the given m/z ratio.  The spectra 
obtained for (phen)Re(THF)(CO)2OTf (figure A2.1) exhibited a major m/z peak at 391.2 
corresponding to Re(NO)(CO)2(acetone)2, in addition to several solvation products 
exhibited in Table A2.2. 
Table A2.1 List of most important ESI-MS positive mode signals of 
(phen)Re(THF)(CO)2OTf upon reaction with NO-donor. 
 
The spectra obtained for (phen)Re(PPh3)(CO)2OTf (figure A2.2) exhibited a 
major m/z peak at 339.4 corresponding to Re(NO)2(CO)2(H2O)2, in addition to several 
solvation products exhibited in Table A2.3 
m/z ratio
Relative 
abundance
Possible Structure
186.3 55 Re
338.4 50
354.2 95
391.2 100 - 100
492.1 80
ReH3CCN
CO
CO
NCCH3
CO
Re(H3C)2CO
CO
CO
OC(CH3)2
NO
N
N
Re
CO
OC(CH3)2
OH2
OH2
Re
CO
CO
OC(CH3)2
H2O
H2O
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Table A2.2 
 List of most important ESI-MS positive mode signals of (phen)Re(PPh3)(CO)2OTf  
upon reaction with NO-donor. 
 
 (phen)Re(CO)3Cl and (phen)Re(CO)3OTf were used as controls.  The mass 
spectra of these complexes showed no Re –NO containing  products (Tables A2.3 and 
A2.4). 
 
 
 
 
 
m/z ratio
Relative 
abundance
Possible Structure
339.4 100 - 50
395.5 100
431.3 45
453.3 60
Re
H2O
H2O CO
CO
NO
NO
(H3C)2CO
(H3C)2CO
Re
CO
OH2
OH2
CO
N
N
Re
OH2
OH2
CO
Re(H3C)2CO CO
CO
OH2
OH2
(H3C)2CO CO(CH3)2
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Table A2.3 List of most important ESI-MS positive mode signals of (phen)Re(CO)3Cl  
upon reaction with NO-donor. 
 
Table A2.4 List of most prominent ESI-MS positive mode signals of (phen)Re(CO)3OTf  
upon reaction with NO-donor. 
 
m/z ratio
Relative 
abundance
Possible Structure
186.4 72 Re
242.4 50 Re(OH)3
346.5 70
492.2 100 - 45
Re
CO
OC(CH3)2
OH2
OH2H2O
H2O
N
N
Re
CO
OC(CH3)2
OH2
OH2
m/z ratio
Relative 
abundance
Possible Structure
186.4 70 Re
242.4 50 Re(OH)3
338.4 48
346.4 56
492.1 100 - 40
Re
CO
CO
OC(CH3)2
H2O
H2O
Re
CO
OC(CH3)2
OH2
OH2H2O
H2O
N
N
Re
CO
OC(CH3)2
OH2
OH2
146 
 
The mechanism of action of these phen-Re(I) fluorescent dyes is complex: Two 
different paths can be identified by spectroscopic techniques: a. Reaction with NO, by 
elimination of two ligands; b. Deactivation of the initial complex by solvation 
(substitution with acetone, acetonitrile or water).   
A2.5. CONCLUSION 
ESI-MS m/z ratios can be useful to predict possible products after the reaction 
with NO-donor.  NO-active complexes (phen)Re(PPh3)(CO)2OTf (1) and 
(phen)Re(THF)(CO)2OTf (2) exhibited m/z ratio signals that can be ascribed as NO-Re 
containing species.  Control complexes (phen)Re(CO)3OTf and (phen)Re(CO)3Cl only 
exhibited solvation byproduct, without NO in them.  Other important fact is that all these 
formed complexes have net charge of +1; charged complexes cannot pass through the 
phospholipidic bilayer cell membrane. 
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